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of health. Comparing objective performance measures and their self-reported equivalents
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higher out-of-pocket spending (17% more). We project that underestimating health of the
population 50+ will cost the average European country Intl$ 71 million in 2020 and Intl$ 81
million by 2060. Country-specific estimates based on population and demographic projec-
tions show that countries such as Germany, Denmark and The Netherlands will experience
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Health Misperception and Healthcare Utilisation
among Older Europeans
Sonja Spitzer and Mujaheed Shaikh
1 Introduction
Biased perception of one’s own ability is a hallmark of human nature. The literature in
psychology, economics, and evolutionary biology has repeatedly demonstrated this phe-
nomenon. Zell & Krizan (2014) conducted a meta-synthesis across different scientific areas
and concluded that people have only moderate knowledge of their ability. Johnson & Fowler
(2011) presented an evolutionary model of one such bias, namely, overconfidence, and the
conditions under which it prevails. Such biases have significant implications for education,
labour market outcomes, savings, investment choices, and political decisions (Anderson
et al. 2017, Ortoleva & Snowberg 2015, Reuben et al. 2017). They are particularly relevant
for health, as they can directly affect risk for accident and injury (Preston & Harris 1965,
Sakurai et al. 2013) and have serious long-lasting effects on wellbeing and mortality. Recent
work in this domain shows that overconfidence is related to engagement in risky health be-
haviours (Arni et al. 2019).
Despite the relevance of biased perception for health, its role in healthcare seeking is largely
unexplored. Here we study the relationship between misperception of one’s own health
and future healthcare utilisation and medical expenditures. We categorise misperception as
arising from either overconfidence or underconfidence in one’s own health. Following the
literature in psychology, we measure overconfidence as the overestimation of one’s actual
health and measure underconfidence as the underestimation of one’s actual health (Moore
& Healy 2008). It is a priori ambiguous how over- or underconfidence might relate to health-
care use. On the one hand, individuals who overestimate their health may be less likely to
visit the doctor when necessary, seek medical attention, or receive timely screenings because
they believe their health is perfect. These individuals might also engage in more physical ac-
tivity, which decreases healthcare utilisation (Rocca et al. 2015). On the other hand, the same
individuals might engage in activity or behaviour detrimental to health and thus end up in
the hospital more often. For example, older individuals who overestimate their mobility
are more prone to fall-induced injuries (Sakurai et al. 2013). Similarly, individuals who un-
derestimate their health may overutilise healthcare services by seeking care and purchasing
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relatively more medication when it is not necessary—at least in the short run. In the long
run, however, they might need less care and use fewer services because of their frequent
doctor visits and timely diagnoses. Assessing the relationship between health perception
and healthcare utilisation thus remains an empirical task that we undertake in this study.
Measuring over- or underconfidence bias in health is anything but trivial. It requires a sub-
jective health measure and its objective equivalent, the lack of which often dissuades re-
searchers from engaging in such research. We use a novel indicator to measure over- and
underconfidence that is derived from the objective performance measures in the Survey of
Health, Ageing and Retirement (SHARE). We analyse differences between subjective and
objective health based on individuals’ self-reported and tested ability to stand up from a
chair. Individuals who subjectively report being able to stand but objectively are unable to
do so are classified as overconfident, whereas those who subjectively report being unable to
stand but objectively are able to are classified as underconfident. Individuals who do not
differ in their subjective report and objective assessment are classified as concordant. Prior
research has shown the chair stand test to be a good predictor of overall health (Ferrer et al.
1999, Sainio et al. 2006, Pinheiro et al. 2016, Spitzer & Weber 2019). Our approach distin-
guishes our measure of overconfidence from overplacement and overprecision because we
focus only on individual judgements of completing a task rather than on relative compar-
isons with others or the estimated accuracy of such judgements (Moore & Healy 2008).
To assess utilisation, we use self-reported data on the annual number of doctor visits, which
includes emergency room visits and outpatient clinic visits. Using count models, a rich set
of controls, and longitudinal data, we find that relative to individuals who achieve con-
cordance (i.e., those who estimate their health accurately), individuals who underestimate
their health visit the doctor more often (approximately two more visits per year). In con-
trast, individuals who overestimate their health visit the doctor less often. We also analyse
concomitant out-of-pocket (OOP) expenditures via log-Gamma models and find that indi-
viduals who underestimate their health have higher expenses, whereas individuals who
overestimate their health have lower expenses. Our results are not biased by other individ-
ual characteristics, such as education, age, employment, or marital status, nor are they a
manifestation of the inverse relationship between healthcare utilisation and the estimation
of one’s health as already stated. The results are robust to different model specifications,
estimation methods, and measures of health perception.
We use data from 15 European countries from the SHARE survey, which provides other
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advantages besides a measure of confidence. First, the longitudinal nature of the survey al-
lows us to assess the relationship between confidence today and healthcare utilisation in the
next wave of the survey. Thus, an important source of bias in our estimates—reverse causal-
ity—is not a first-order issue in our analyses. Second, utilising health services is conditional
on having access to such services; a fair comparison of utilisation requires no significant dif-
ference in accessibility among the entities being compared. Universal coverage in European
countries ensures that everyone has a certain level of access to the health system, unlike in
the United States (OECD & European Commission 2018). Finally, Europe is a policy-relevant
setting because of its rapidly ageing population (Lutz et al. 2003, Eurostat 2019) and fiscal
pressures to reduce expenditures and unnecessary care (Christensen et al. 2009, European
Commission 2018).
To quantify the public expenditure associated with health misperception, we perform a
back-of-the-envelope calculation of the costs of health misperception. We project that un-
derestimating health will cost the average European country Intl$ 71 million in 2020 and
Intl$ 81 million by 2060. Although overestimating health results in negative costs due to
lower numbers of doctor visits, these are in the short run only. In the long run, overesti-
mation may result in individuals skipping timely screening and preventive care and lead to
worse health, resulting in higher healthcare expenditures.
The contribution of this study is twofold. First, we introduce and advance a measure of
health misperception in the health economics literature. Our measure of over- and under-
confidence is simple and easy to calculate and an accurate indicator of health status. The
medical literature has shown the chair stand test to be strongly correlated with physical
health (Ferrer et al. 1999, Sainio et al. 2006, Pinheiro et al. 2016). Moreover, it is regularly
performed in other surveys, such as the English Longitudinal Study of Ageing, which pro-
vides the opportunity to study different settings and make subsequent comparative analyses
between countries.
Second, we contribute to at least two strands of the literature in health economics. The lit-
erature has repeatedly shown that individuals frequently over- or underestimate their own
health status (Bago d’Uva et al. 2008, Beaudoin & Desrichard 2011, Coman & Richardson
2006, Furnham 2001, Jürges 2007). In addition, health perception differs by sociodemo-
graphic characteristics such as age (Srisurapanont et al. 2017, Crossley & Kennedy 2001),
gender (Schneider et al. 2012, Merrill et al. 1997), country of residence (Spitzer & Weber
2019, Capistrant et al. 2014, Jürges 2007), education (Bago d’Uva et al. 2008, Choi & Caw-
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ley 2017), and race (Jackson et al. 2017). The difference between subjective and predicted
survival probability affects healthcare utilisation (Bíró 2016a), and individuals with higher
expected longevity are more likely to go for cancer screening (Picone et al. 2004), suggesting
that health perception affects healthcare utilisation. Our paper contributes to this strand by
directly studying over- and underconfidence in one’s own health.
It also contributes to the literature on the determinants of healthcare use. In explaining vari-
ation in health expenditures and healthcare utilisation, this literature focuses on either the
supply side (i.e., provider confidence and precision) (Baumann et al. 1991, Berner & Graber
2008, Cutler et al. 2013, Meyer et al. 2013) or easily observable demand characteristics (e.g.,
age, gender, income, social class, employment and education) (Bíró 2013, Cameron et al.
2010, Tavares & Zantomio 2017, Vallejo-Torres & Morris 2013, Van Doorslaer et al. 2004,
Zhang et al. 2018). Our paper makes a novel contribution by extending this literature to as-
sess a difficult-to-observe demand variable that has consistently been shown to affect health.
The remainder of this paper is structured as follows. In Section 2, we describe the data and
variables. In Section 3, we introduce our methodology. Section 4 presents and discusses the
results, Section 5 describes a range of robustness analyses, Section 6 provides estimates for
the total public cost of health misperception, and Section 7 concludes the paper.
2 Data and Descriptive Statistics
We analyse the relationship between health misperception and healthcare utilisation based
on SHARE, a representative cross-country panel study of noninstitutionalised individuals
ages 50 and older as well as their younger spouses (Börsch-Supan et al. 2013).1 The survey
provides rich information on health, socioeconomic background, employment, and social
networks based on about 380,000 interviews with around 140,000 individuals. It is particu-
larly well suited for studying European countries, as the data are ex-ante harmonised. Also,
because it focuses on older individuals, who generally have higher healthcare needs than
the young, it is the ideal data source for our analyses. SHARE was previously used to anal-
1This study uses data from SHARE Waves 1, 2, 4, 5, and 6 (DOIs: 10.6103/SHARE.w1.700,
10.6103/SHARE.w2.700, 10.6103/SHARE.w4.700, 10.6103/SHARE.w5.700, 10.6103/SHARE.w6.700). SHARE
data collection has been funded by the European Commission through FP5 (QLK6-CT-2001-00360), FP6
(SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812), FP7
(SHARE-PREP: GA N211909, SHARE-LEAP: GA N227822, SHARE M4: GA N261982), and Horizon 2020
(SHARE-DEV3: GA N676536, SERISS: GA N654221) and by DG Employment, Social Affairs & Inclusion. Ad-
ditional funding from the German Ministry of Education and Research, the Max Planck Society for the Ad-
vancement of Science, the U.S. National Institute on Aging (U01_AG09740-13S2, P01_AG005842, P01_AG08291,
P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064, HHSN271201300071C), and var-
ious national funding sources is gratefully acknowledged (see www.share-project.org).
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yse healthcare utilisation by, among others, Bíró (2014), Bolin et al. (2009), Paccagnella et al.
(2013), and Tavares & Zantomio (2017).
2.1 Sample Construction
The chair stand test, which we use to determine our measure of over- and underconfidence,
is used only in SHARE Wave 2 (2006/2007) and Wave 5 (2013). Because we are assessing
the relationship between this measure of confidence and healthcare utilisation in the next
wave, our dependent variables, namely, annual number of doctor visits and concomitant
OOP expenditures, are taken from the next waves, that is, Wave 4 (2010–2012)2 and Wave 6
(2015) (Börsch-Supan 2019b,c). Hence, we treat the data as pooled cross-sections by match-
ing individuals’ misperception at Waves 2 and 5 (w) with their utilisation at Waves 4 and 6
(w + 1), respectively.
Our dependent variables are taken from wave w + 1, which is why we drop all observations
that do not provide information on doctor visits at wave w + 1. This affects mostly respon-
dents who participated in Wave 2 but not in the subsequent Wave 4 or respondents who
participated in Wave 5 but not in the subsequent Wave 6. We also exclude all respondents
younger than 50 years and all observations based on proxy respondents. Overall, this re-
sults in 58,897 observations from 15 European countries, namely, Austria, Belgium, Czechia,
Denmark, Estonia, France, Germany, Italy, Luxembourg, The Netherlands, Poland, Slovenia,
Spain, Sweden, and Switzerland. The sample for OOP payments is smaller (41,868 observa-
tions), as OOP payments were not captured in Wave 4 (Section 2.2.2).
Based on their results on the chair stand test, we categorise individuals into three groups:
those who achieve concordance (i.e. subjectively report having no problem standing up
from the chair and objectively are able to or subjectively report having problems standing
up from the chair and objectively are not able to), those who are overconfident (i.e., over-
estimate their health; subjectively report being able to stand up but objectively are unable
to), and those who are underconfident (i.e., underestimate their health; subjectively report
being unable to stand up but objectively are able to). With concordance as the reference cat-
egory, the sample is split into two groups: those who are overconfident and those who are
underconfident. Further details are provided in Section 2.3.
For the main analysis, health misperception is based on the chair stand variables, because
they are binary and therefore clearly indicate whether an individual is unimpaired or im-
2SHARE Wave 3 focuses on people’s life histories and thus is not utilised in our analyses.
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paired. For robustness, we use additional measures of health perception based on subjec-
tive cognition and walking ability and their objective counterparts. We therefore add more
waves to the analyses for robustness (Section 5.5).
2.2 Outcome Variables
In line with the literature, we use the annual number of doctor visits as a proxy for health-
care utilisation (see Bago d’Uva & Jones 2009, Bíró 2016b, Bolin et al. 2009, Lugo-Palacios
& Gannon 2017, Tavares & Zantomio 2017, Zhang et al. 2018, among others). By analysing
this number, we are able to capture the effects of health perception on public expenditures,
as doctor visits are frequently subsidised by the public. In addition, doctor visits are good
indicators of healthcare seeking in general and preventive healthcare and screenings in par-
ticular. In addition to doctor visits, we analyse annual OOP payments for doctor visits,
which allows us to analyse the effects of health perception on private healthcare expenses.
2.2.1 Annual Doctor Visits
The annual number of doctor visits, emergency room visits, and outpatient clinic visits is as-
certained by answers to the following question: “Now please think about the last 12 months.
About how many times in total have you seen or talked to a medical doctor or qualified/
registered nurse about your health? Please exclude dentist visits and hospital stays, but in-
clude emergency room or outpatient clinic visits.” The survey question is phrased almost
identically in Waves 4 and 6; however, the words “or qualified/registered nurse” are ex-
cluded in Wave 4. For this and other reasons, we run separate estimations for each wave as
a sensitivity analysis (Section 5.4).
The number of doctor visits is top-coded at 98 visits per year. On average, individuals in
our sample visit the doctor seven times per year. The median, however, is lower (five times),
which demonstrates the variable’s strong right-skewness (Table 2). Naturally, individuals
who suffer from chronic diseases or activity limitations visit the doctor more frequently
than healthy individuals; thus, the number of doctor visits also increases with age. Gender
differences in doctor visits are clear: Women have more annual doctor visits than men. A
socioeconomic gradient is also observed with respect to education: The number of doctor
visits decreases as education increases. It is interesting that individuals with supplemen-
tary insurance have fewer doctor visits than those without, a finding quite contrary to the
literature, which predicts moral hazard with supplemental insurance (Coulson et al. 1995,
Buchmueller et al. 2004) (see Table A.1 in the Appendix).
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2.2.2 OOP expenditures for doctor visits
If participants report that they have seen or talked to a doctor, they are asked, “Did you
pay anything yourself for your doctor visits (in the last twelve months)? Please also include
expenses for diagnostic exams, such as imaging or laboratory diagnostics.” If they answer
“yes”, they are then asked, “Overall, how much did you pay yourself for your doctor visits
(in the last twelve months), that is how much did you pay without getting reimbursed by (a
health insurance/ your national health system/ a third party payer)?” The amount of OOP
payments is based on the latter question; it is set to zero if the respondent did not visit a
doctor at all or if he or she claims zero payments for doctor visits. All values are presented
in Euros. Implausibly large values are set to missing, as suggested by SHARE (Jürges 2015).
This affects 3,006 observations.
OOP payments are available in Wave 6 but not in Wave 4; thus, we assess the association
between health perception at Wave 5 (w) and OOP expenditures at Wave 6 (w + 1) only. Con-
sequently, the sample is smaller for analyses of OOP payments than those of doctor visits.
Because potential deductibles include expenditures for not only doctor visits but also other
healthcare services, such as dentist visits and hospital stays, we do not consider deductibles
when calculating the OOP expenditures variable.
The mean OOP expenditure is 73 Euros per year. However, 61% of the participants have
zero OOP payments at Wave 6; thus, the median is zero (Table 2). It is interesting that OOP
payments do not increase with the number of chronic diseases or activity limitations, but
educational attainment has a strong positive correlation with OOP expenditures. Further-
more, mean OOP payments vary substantially between countries: They are highest in Lux-
embourg, Switzerland, Italy, and Austria, reflecting differences in utilisation and/or cost-
sharing mechanisms (Paccagnella et al. 2013) (see Table A.2 in the Appendix).
2.3 Explanatory Variable: Health Perception
Following the literature in psychology, our measure of misperception relates to the most
common interpretation of over- and underconfidence, namely, over- and underestimating
one’s performance, actual ability, chance of success, or level of control (Moore & Healy
2008). Assuming an underlying true level of health, we group individuals according to their
perception of their health status. More specifically, we differentiate among individuals who
perceive their health status correctly (concordance), those who believe that they are healthier
than they really are (overestimation), and those who believe that they are unhealthier than
they really are (underestimation). The true level of health is proxied by objective perfor-
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Figure 1: Survey question ascertaining subjective impairment (response category proportions in brackets)
Figure 2: Sequence of questions ascertaining objective impairment (response category proportions in brackets)
mance measures data based on physical performance measures. This objective information
about the respondent’s health is matched with the respondent’s subjective assessment of his
or her health, thus revealing whether that individual’s beliefs are correct or not.
SHARE provides several objective performance measures that can be utilised as proxies for
true health. The measure most suited to analysing differences between objective and subjec-
tive health is the ability to stand up from a chair, as this self-assessed variable relates directly
to its tested equivalent. This measure has been used previously in Spitzer & Weber (2019). In
additional analyses, we also observe the differences between subjective and objective cogni-
tion as well as subjective and objective walking ability (Section 5.5).
To evaluate subjective ability to get up from a chair, survey participants are asked whether
they have difficulties getting up from a chair. Figure 1 provides the detailed survey question.
Individuals are considered subjectively impaired if they report difficulties getting up from a
chair and subjectively unimpaired if they do not. Overall, 17.0% of the survey participants
in our sample are considered subjectively impaired. Both the impaired and unimpaired
groups are then subjected to the objective assessment.
In the objective assessment, individuals are asked to physically stand up from a chair.3
The chair stand test is introduced with the interviewer saying, “The next test measures the
strength and endurance in your legs. I would like you to fold your arms across your chest
and sit so that your feet are on the floor; then stand up keeping your arms folded across
your chest. Like this . . . ” The exact sequence of questions leading to the chair stand test
is shown in Figure 2. Individuals are considered objectively unimpaired if they stand up
3It is important to note that the chair stand test in Wave 2 was only conducted among those younger than 76
years. Thus, the sample is younger than 76 for any country that participated only in Wave 2.
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Table 1: Overview health perception categories
Objectively
Subjectively Unimpaired Impaired
Unimpaired Pos. concordance: 87.6% Overestimating: 56.9%
Impaired Underestimating: 12.4% Neg. concordance: 43.1%
Total 100.0% 100.0%
Note: No weights applied
without using their arms and objectively impaired if they are not able to stand up from the
chair, if they have to use their arms to stand up, or if they think it is unsafe to try to stand
up from the chair.
Following the subjective report of impairment (i.e., unimpaired or impaired) and the sub-
sequent objective test, individuals can either achieve concordance, overestimate their own
health, or underestimate their own health. If they subjectively report being unimpaired
but are objectively impaired, they overestimate their health. Likewise, if they subjectively
report being impaired but are objectively unimpaired, they underestimate their health. Al-
though the categorisation of over- and underestimation is straightforward, the categorisa-
tion of concordance (i.e., accurate beliefs about their health status) requires further consid-
eration. Given true (objective) health, it is important to distinguish between two types of
concordance. Individuals with a poor health status (i.e., objectively impaired) are classified
as “negative concordance” if they also subjectively report being impaired. Likewise, indi-
viduals with a good health status( i.e., objectively unimpaired) are classified as “positive
concordance” if they also subjectively report being unimpaired. The four health perception
outcomes are shown in Table 1.
Distinguishing between the two types of concordance ensures that we use the appropriate
reference category for over- and underestimation in regression analyses. Overestimation
can only be measured in the group whose objective health is impaired yet who subjectively
report being unimpaired. Therefore, an appropriate group of individuals to compare to are
those who are also objectively impaired (i.e., negative concordance). Underestimation can
only be measured in the group whose objective health is unimpaired yet subjectively report
impaired. The appropriate comparator for these individuals is the group that is also objec-
tively unimpaired. This separation of the concordance group also provides an important
empirical advantage; it ensures that we compare like with like in terms of true initial health
thereby ridding ourselves of an important source of endogeneity, namely variation in health
that can determine utilisation.
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Table 2: Summary statistics
N Mean Std. Dev. Min. Max. Median
Healthcare utilisation
Annual number of doctor visits at w+1 58,764 7.332 9.423 0 98 5
Annual out-of-pocket expenditure for doctor visits at w+1 39,988 73.349 298.196 0 47,500 0
Health perception
Positive concordance (1 = yes) 56,152 0.743 0.437 0 1 1
Underestimating (1 = yes) 56,152 0.101 0.302 0 1 0
Negative concordance (1 = yes) 56,152 0.060 0.237 0 1 0
Overestimating (1 = yes) 56,152 0.096 0.295 0 1 0
Impairment
Subjective impairment (1 = impaired) 58,758 0.170 0.376 0 1 0
Objective impairment (1 = impaired) 56,157 0.156 0.363 0 1 0
Health variables
Number of chronic diseases at w 58,702 1.145 1.217 0 10 1
Number of chronic diseases at w+1 58,754 1.207 1.231 0 9 1
Number of activity limitations at w 58,755 0.357 1.177 0 13 0
Number of activity limitations at w+1 58,752 0.490 1.451 0 13 0
Control variables
Age (in number of years) 58,764 64.521 9.765 50 100 63
Gender (1 = female) 58,764 0.545 0.498 0 1 1
Low education (1 = yes) 57,979 0.430 0.495 0 1 0
Medium education (1 = yes) 57,979 0.369 0.483 0 1 0
High education (1 = yes) 57,979 0.201 0.401 0 1 0
Is retired (1 = yes) 58,471 0.509 0.500 0 1 1
Is married (1 = yes) 56,883 0.680 0.466 0 1 1
Household income (in Euros per year) 58,764 46,569.89 76,244.77 0 1,200,000 24,000
Health access (1 = difficult) 39,120 0.163 0.370 0 1 0
Note: Calibrated cross-sectional individual weights are applied. For more detailed cross-tabulations see Tables A.1 to A.3 in
the Appendix.
As shown in Table 1, in the objectively impaired group, 57% overestimate their health status;
in the unimpaired group, only 12% underestimate. The large number of people reporting
overconfidence is not surprising, as it has been documented in psychology and evolution-
ary theory as being favoured by natural selection and providing adaptive gains. Individ-
uals tend to be overconfident because it increases morale and ambition and may thus im-
prove potential (Johnson & Fowler 2011). Furthermore, our sample consists of older people,
among whom overconfidence is particularly prevalent (Idler 1993, Spitzer & Weber 2019)
and is seen as a resilience strategy to maintain a positive self-image (Brandtstädter & Greve
1994).
2.4 Additional Control Variables
We control for a range of variables that might otherwise confound our results. Summary
statistics for these control variables are provided in Table 2, and cross-tabulations of con-
trol variables, doctor visits, health expenditures, and health perception are provided in Ta-
bles A.1 to A.3 in the Appendix. Most important, we control for other health factors at wave
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w. In particular, we include the number of chronic diseases and the number of limitations
in instrumental activities of daily living (IADLs) in our model. Chronic conditions that we
consider are heart problems, high blood pressure or hypertension, high blood cholesterol,
stroke or cerebral vascular disease, diabetes, chronic lung diseases, cancer, stomach or duo-
denal ulcer, Parkinson’s disease, cataracts, hip fractures, other fractures, and Alzheimer’s
disease. A total of 35% of the sample have no chronic diseases at wave w; the weighted
mean is 1.2 diseases. IADLs that we consider are difficulties dressing, walking across a
room, bathing or showering, eating and cutting up food, getting in or out of bed, using the
toilet, using a map, preparing a hot meal, shopping for groceries, making a telephone call,
taking medications, doing work around the house or garden, and managing money. A total
of 81% of the sample have no IADLs at wave w; the weighted mean is 0.5 IADLs. We only
consider chronic diseases and IADLs that are included in both Wave 2 and Wave 5.
We also control for sociodemographic characteristics, as they are expected to influence health
perception as well as healthcare utilisation (Avitabile et al. 2011, Lange 2011). In particu-
lar, we include age and age squared, gender, and educational attainment according to the
International Standard Classification of Education (Eurostat 2018). Because pensioners ap-
pear to have higher healthcare utilisation (Bíró 2016b, Zhang et al. 2018), we also consider
whether an individual is retired as opposed to all other employment options (employed,
self-employed, unemployed, permanently sick or disabled, homemaker, other). Also, we
control for whether the survey participant is married or in a registered partnership as op-
posed to never married, divorced, or widowed.
The effects of economic resources on healthcare utilisation are considered via equivalised
household income. Because there are many missing values for household income in SHARE,
the data set comes with two additional imputed variables. We use one of these imputed
variables in our model and conduct a robustness analysis with the other (Section 5.4). We
equivalise household income by using the square root scale, in which household income
is divided by the square root of household size. Using the Organisation for Economic Co-
operation and Development equivalence scale is not feasible, as children cannot be iden-
tified unambiguously. Furthermore, we use a cube root transformation to normalise the
skewed income distribution (Cox 2011). Standard log normalisation is not feasible because
of the substantial number of zero values.4 We run a robustness analysis in which we use
equivalised household income that was not normalised (Section 5.4).
4Results are robust to dropping observations with zero values in household income.
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3 Method
Ideally, we would randomly assign health perception to individuals to elicit causal effects
of (mis)perception on healthcare utilisation and expenditures. In the absence of such ran-
dom assignment, we rely on the panel dimension of the SHARE survey and control for a
rich set of variables to account for confounding effects and bias due to reverse causation.
Health perception is expected to affect healthcare utilisation, but the opposite mechanism,
that healthcare utilisation precedes health perception, appears plausible too. For example,
individuals who frequently visit the doctor are more likely to achieve concordance, as they
receive more information about their health status. To overcome potential endogeneity, we
analyse the effects of current health perception (wave w) on future healthcare utilisation
(wave w + 1).
The main outcome variable—annual doctor visits—is strongly skewed to the right, yet with-
out severe mass at zero. To accommodate this, we use a negative binomial model with mean
dispersion, which is used frequently in the healthcare literature. We refrain from using a
simple Poisson model, as the variance in the outcome variable is much larger than its mean.
However, we perform robustness analyses using different models (Section 5.4). Thus, the
number of doctor visits of individual i at wave w + 1 (DOCTORi,w+1) is assumed to follow
a Poisson distribution but with a negative binomial specification for which each individual
unit has a separate, Gamma-distributed mean. More specifically,
DOCTORi,w+1 ∼ Poisson(µi,w+1), (1)
where
µi,w+1 = exp(β × HEALTH PERCEPTIONi,w + γ × HEALTHi,w + δ × Xi,w + νi), (2)
and
exp(νi) ∼ Gamma(1/α, α) (3)
HEALTH PERCEPTION is a binary variable that indicates whether individual i achieves
concordance or misperceives his or her health at wave w. The vector HEALTH includes
two variables, namely the number of chronic diseases in period w as well as the number of
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IADLs in period w (thus, in the same period as health perception). The vector of control vari-
ables Xi,w includes age and age squared, the individual’s gender, educational attainment,
household income, and control dummies for the survey wave as well as for the country of
residence. The terms β, γ, and δ represent coefficients.
As discussed earlier, the sample is split into individuals who are overconfident (i.e., over-
estimate their health status) and individuals who are underconfident (i.e., underestimate
it). The regression coefficients are therefore interpreted relative to those who estimate their
health correctly (i.e., achieve concordance). For heterogeneity analyses, we further split the
sample by gender, country, and number of chronic diseases.
When analysing the effects of health perception on OOP expenditures, we use a nonlinear
model with a log link and Gamma family instead of the negative binomial model to account
for the continuous nature of the outcome variable as well as for the excess zeros (Deb &
Norton 2018). The specification of the variables included, however, remains identical to that
described in Equation 2.
A total of 32% of the survey respondents participate in Waves 2, 4, 5, and 6, which allows
us to analyse how health perception varies between Wave 2 and Wave 5 for these observa-
tions. For the majority (75%), health perception does not vary with age. If health perception
changes, the most common changes are from underestimating to concordance (7.6%), from
concordance to overestimating (6.5%), and from concordance to underestimating (5.6%). Be-
cause there is not enough variation in health perception within individuals, we refrain from
using individual fixed effects in our analyses.
In Section 5.5, we explore whether our results are robust to different specifications of health
perception. In particular, we estimate Equation 2 using cognition and the ability to walk as
bases for the health perception variable.
4 Results
We first present the main results for the link between health misperception and health-
care utilisation and expenditures. We then examine heterogeneity in the relationships and
present the results of important robustness analyses. Finally, we provide results for alterna-
tive measures of health perception bias.
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4.1 Main Results
Table 3: Annual number of doctor visits and OOP expenditures for doctor visits at w+1


















Chronic diseases 0.181∗∗∗ 0.118∗∗∗ 0.149∗∗∗ 0.118∗
(0.005) (0.031) (0.009) (0.055)
Activity limitations 0.096∗∗∗ 0.088 0.048∗∗∗ 0.031
(0.010) (0.045) (0.007) (0.030)
Age -0.001 0.082 0.021 0.165∗
(0.011) (0.058) (0.018) (0.082)
Age squared 0.000 -0.001 -0.000 -0.001∗
(0.000) (0.000) (0.000) (0.001)
Woman 0.042∗∗∗ 0.125∗ 0.014 0.422∗∗∗
(0.013) (0.060) (0.028) (0.117)
Educ. group (ref.: low)
Medium 0.006 0.419∗∗∗ -0.006 0.112
(0.016) (0.072) (0.033) (0.126)
High -0.003 0.881∗∗∗ -0.087∗ 0.544∗∗∗
(0.018) (0.093) (0.042) (0.152)
Retired 0.029 -0.031 0.014 0.398
(0.017) (0.104) (0.033) (0.228)
Married -0.034∗ 0.029 0.019 0.405∗∗∗
(0.015) (0.072) (0.030) (0.115)
Equiv. hh income (cube root) -0.001 0.014∗∗∗ -0.001 0.006
(0.001) (0.003) (0.002) (0.007)
Wave 5 -0.089∗∗∗ -0.046
(0.015) (0.038)
Constant 1.507∗∗∗ 0.626 1.434∗ -1.232
(0.356) (1.963) (0.646) (2.828)
Country dummies Yes Yes Yes Yes
N 46,067 32,564 7,801 5,603
AIC 260,957 297,483 50,545 50,035
BIC 261,202 297,684 50,740 50,194
Note: “Unimpaired” refers to the sample that is objectively unimpaired, i.e. able to stand up from the chair and “Impaired”
refers to the sample that is objectively impaired, i.e. unable to stand up from the chair. The dependent variable “doctor visits”
is based on the annual number of doctor visits, visits to emergency rooms and outpatient clinic visits at wave w+1, i.e. Wave
4 or Wave 6. All explanatory variables are taken from wave w, i.e. Wave 2 or Wave 5 respectively. The estimated coefficients
are based on a negative binomial regression model with mean dispersion. The dependent variable “OOP” is based on annual
out-of-pocket payments for doctor visits at wave w+1, i.e. Wave 6. All explanatory variables are taken from wave w, i.e. Wave
5. The coefficients are estimated based on a generalised linear model model with log link and a Gamma family. Standard
errors are clustered at the household level and presented in parentheses. * p<0.05, ** p<0.01, *** p<0.001
4.1.1 Healthcare Utilisation
Healthcare utilisation is measured by the annual number of doctor visits. Table A.1 of the
Appendix shows that overall, individuals who overestimate their health have fewer doctor
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visits (8.6 visits) compared to their reference group (i.e., negative concordance = 11.9 visits).
Similarly, those who underestimate their health have significantly more doctor visits in a
year (10.1 visits) compared to their relevant reference group (i.e., positive concordance = 6.2
visits).
The table also shows cross-tabulations by other characteristics of the sample. Using number
of chronic conditions and activity limitations as proxies for doctor visits provides two im-
portant insights. First, we find that as illness increases, so does the number of doctor visits
irrespective of the category of perception bias. Second, at every level of illness, individuals
who underestimate their health visit the doctor more often than those who are concordant.
Similarly, overall, at almost each level of health (barring a few exceptions), individuals who
overestimate their health visit the doctor less often. This shows that despite the same un-
derlying health status, there is variation in doctor visits by health misperception category.
Starkly similar results are observed for increasing age.
Although the picture is somewhat mixed across education categories, we observe fewer
doctor visits for overestimators relative to their concordant counterparts at every level of
education. Similarly, underestimators have higher healthcare utilisation than their concor-
dant counterparts at each level of education. Accessibility to health professionals strongly
determines health access; the pattern of utilisation across this variable by our misperception
category remains the same as before: Overestimation shows fewer doctor visits, and un-
derestimation shows more visits. Similar results are observed by supplementary insurance
status.
These descriptive findings show that despite conditioning on individual characteristics,
there is clear variation in healthcare utilisation in the form of doctor visits among the differ-
ent health perception categories. In the regression analyses, we control for these and other
variables such as country dummies. Table 3 shows the regression results. Columns 1 and
3 show the results for the two groups (i.e., overestimators and underestimators categorised
based on the objective health status as impaired or unimpaired). All coefficients are to be
interpreted relative to the concordance category.
We find a strong and significant association between health misperception and healthcare
utilisation. Individuals who underestimate their health visit the doctor 27.6% more often in
the subsequent period than individuals who achieve concordance. Computing marginal ef-
fects at means shows that this results in approximately two additional doctor visits per year.
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We also find a strong and significant link between overestimation and the annual number
of doctor visits. Individuals who overestimate their health go to the doctor less often than
those who achieve concordance. Overestimating health at wave w results in 13.6% fewer
doctor visits at wave w + 1 compared to perceiving one’s health correctly. The marginal ef-
fect at means of overestimating health on healthcare utilisation is approximately 1.3 fewer
doctor visits per year.
The results for doctor visits in Table 3 are based on a negative binomial model with mean
dispersion. Figures 3 and 4 show that this model has the best fit among a simple Poisson
model, a negative binomial model with constant dispersion, and a zero-inflated Poisson
model.
4.1.2 OOP Expenditures
Individuals who visit a doctor also report OOP expenses, if any, measured in Euros. Ta-
ble A.2 shows descriptive cross-tabulations of OOP expenditures incurred by other individ-
ual characteristics and by misperception category. Although no consistent pattern in OOP
spending emerges by the number of chronic conditions, number of activity limitations, or
increasing age, women show slightly higher expenditures than men. A clear education gra-
dient is also observed in OOP spending, with higher education relating positively to spend-
ing. Similarly, retired individuals spend more than those who are not retired, as do married
individuals compared to single ones. It is not surprising that in general individuals with
supplementary insurance spend slightly less than those without it, and those with difficulty
accessing healthcare spend less than those with no difficulty. Certain countries, such as
Switzerland, Luxembourg, and Italy, show exceptionally high OOP expenditures, whereas
others, such as France, Denmark, and Eastern European countries, show much lower OOP
expenditures, which partly reflects institutional differences in user charges and the coverage
of certain services.
It is interesting that we observe similar patterns as for doctor visits across the misperception
categories. At almost every level of chronic conditions, activity limitations, and increasing
age, we find that those who underestimate their health have higher OOP spending than
those who achieve concordance. The findings for overestimation are somewhat mixed. Un-
derestimating men (women) have slightly lower (much higher) OOP spending than their
concordant counterparts. Overestimating men (women) also have slightly lower (higher)
OOP spending than their concordant counterparts. Although an education gradient can be
seen for underestimators with higher OOP spending compared to the concordant group at
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Figure 3: Count model comparison for the annual number of doctor visits in the unimpaired sample, i.e. able to stand up from the chair
Note: Doctor visits are top coded at 98 visits by year. This figure shows only the first 30 doctor visits for better visualisation. Dark bars represent the empirically observed numbers of doctor
visits and light bars represent the predicted values based on the respective count model.
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Figure 4: Count model comparison for the annual number of doctor visits in the impaired sample, i.e. unable to stand up from the chair
Note: Doctor visits are top coded at 98 visits by year. This figure shows only the first 30 doctor visits for better visualisation. Dark bars represent the empirically observed numbers of doctor
visits and light bars represent the predicted values based on the respective count model.
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each level of education, the same is not observed consistently for overestimators in the
case of lower spending. Although underestimators consistently spend more OOP across
the other individual characteristics, mixed findings are seen for overestimators. Regression
results controlling for these characteristics in Columns 2 and 4 of Table 3 show that individ-
uals who underestimate their health have significantly higher OOP expenses. On average,
expenditures are 16.6% higher for those who underestimate their health compared to those
who achieve concordance. In contrast, individuals who overestimate their health spend
37.8% less in OOP expenditures per year relative to their concordant group.
The results for OOP payments are based on a log-Gamma model. According to Akaike’s
information criterion and the Bayesian information criterion, the log-Gamma model has a
better fit than either a log-Gaussian model or a log-Poisson model.
4.2 Heterogeneity of effects
We assess the heterogeneity of our main results in several ways. In particular, we consider
gender differences, country specificities, and differences by health status.
4.2.1 Gender Differences
The literature has shown differences in health perception by individual characteristics, most
important by gender (Merrill et al. 1997, Schneider et al. 2012). Gender differences in effects
of health beliefs on healthcare utilisation may partly explain the well-documented differ-
ences in healthcare seeking between men and women, as men tend to have lower health-
care use (Galdas et al. 2005, Mansfield et al. 2003, Schlichthorst et al. 2016). Thus, we assess
whether the relationship between health (mis)perception and utilisation also differs between
men and women. As noted earlier, Table A.1 shows that, overall, women have slightly more
doctor visits annually compared to men; this is true also within the misperception cate-
gory, but the difference is not large. Furthermore, both under- and overestimating men and
women have more doctor visits relative to their respective concordant comparators. In the
case of OOP expenditures, however, whereas both under- and overestimating women have
higher spending relative to their concordant group, both under- and overestimating men
have lower spending relative to their concordant group. However, under- and overestimat-
ing women tend to spend more than under- or overestimating men.
Regression analyses by gender reveal that the association between health misperception and
the annual number of doctor visits is slightly larger in magnitude for men than for women
(Table 4). Marginal effects at means show that men who underestimate their health visit
the doctor an additional 1.8 times compared to men who achieve concordance. For women,
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the difference is an additional 1.5 doctor visits. Men who overestimate their health have 1.5
fewer annual doctor visits compared to men who achieve concordance. For women, it is 1.3
fewer visits. A Wald test, however, reveals that the coefficients for women and men are not
statistically different from each other.
4.2.2 Country Specificity
Differences in reporting behaviour by country are well documented (Capistrant et al. 2014,
Jürges 2007, Spitzer & Weber 2019). To ensure that our findings are not driven by differential
reporting due to cultural biases in reporting health or the oversampling of certain countries
in the SHARE survey, we rerun our analyses for each country separately. By and large, we
find similar results for all countries, for both under- and overestimation, with the exception
of a few countries for which we do not find statistically significant results because of small
sample sizes (see Tables A.4 and A.5 in the Appendix). However, it is worth noting that the
magnitude of the coefficient for underestimation is much larger in certain countries, such as
Denmark, Germany, and The Netherlands, than in others, perhaps reflecting differences in
accessibility or other institutional differences in terms of, for example, user charges.
4.2.3 Differences by Health Status
Separating the underestimators and overestimators by objective health status allows us to
overcome an important endogeneity concern related to initial health status that affects both
health perception and healthcare utilisation. However, because we assess healthcare utili-
sation at w + 1, we also assess heterogeneity by health status at w + 1, which allows us to
understand whether current health status drives differential utilisation in any way. Note
that current utilisation at w + 1 will not drive health misperception because we assess mis-
perception at w.
The descriptive statistics in Table A.3 in the Appendix indicate a slight decrease in concor-
dance as the number of chronic diseases increases; however, this trend is far from obvious
and might also be due to the correlation between health and age. To disentangle these ef-
fects, we run separate regressions for those individuals who do not have any chronic dis-
eases at wave w + 1 (healthy) and those who report one or more chronic diseases at wave
w + 1 (unhealthy). The results are reported in Table 5. Although health perception affects the
doctor visits of impaired individuals with and without chronic diseases similarly, underes-
timation has a bigger effect on those without chronic diseases than on those with chronic
diseases—this is confirmed by a Wald test. However, marginal effects reveal no substantial
difference between the healthy and the unhealthy subsamples with respect to the relation-
ship between over- or underestimation and doctor visits. Because we categorise based on
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Table 4: Annual number of doctor visits at w + 1 by gender






















Chronic diseases 0.191∗∗∗ 0.168∗∗∗ 0.176∗∗∗ 0.143∗∗∗
(0.008) (0.014) (0.007) (0.012)
Activity limitations 0.096∗∗∗ 0.045∗∗∗ 0.096∗∗∗ 0.050∗∗∗
(0.018) (0.012) (0.011) (0.008)
Age 0.018 0.038 -0.008 0.014
(0.017) (0.031) (0.013) (0.022)
Age squared -0.000 -0.000 0.000 -0.000
(0.000) (0.000) (0.000) (0.000)
Educ. group (ref.: low)
Medium 0.042 -0.074 -0.027 0.044
(0.026) (0.052) (0.020) (0.041)
High 0.017 -0.151∗ -0.024 -0.055
(0.029) (0.061) (0.024) (0.057)
Retired 0.031 0.075 0.026 -0.026
(0.031) (0.067) (0.021) (0.040)
Married -0.045 0.032 -0.047∗ -0.007
(0.025) (0.055) (0.018) (0.036)
Equiv. hh income (cube root) -0.001 0.000 -0.001 -0.001
(0.001) (0.002) (0.001) (0.002)
Wave 5 -0.116∗∗∗ 0.090 -0.066∗∗∗ -0.124∗∗
(0.022) (0.058) (0.019) (0.047)
Constant 0.654 0.604 1.983∗∗∗ 1.858∗
(0.583) (1.059) (0.441) (0.788)
Country dummies Yes Yes Yes Yes
N 20,693 2,864 25,374 4,937
AIC 116,397 18,426 144,362 32,072
BIC 116,611 18,587 144,582 32,248
Note: “Unimpaired” refers to the sample that is objectively unimpaired, i.e. able to stand up from the chair and “Impaired”
refers to the sample that is objectively impaired, i.e. unable to stand up from the chair. The dependent variable “doctor visits”
is based on the annual number of doctor visits, visits to emergency rooms and outpatient clinic visits at wave w + 1, i.e. Wave
4 or Wave 6. All explanatory variables are taken from wave w, i.e. Wave 2 or Wave 5 respectively. The estimated coefficients
are based on a negative binomial regression model with mean dispersion. Standard errors are clustered at the household level
and presented in parentheses. * p<0.05, ** p<0.01, *** p<0.001
health (in other words, fix health at the same level) we can conclude that the results are not
driven by health differences: Both the healthy group’s and the unhealthy group’s healthcare
utilisation is affected by their health perception in the same direction and to a similar mag-
nitude.
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Table 5: Annual number of doctor visits at w + 1 by chronic diseases at w + 1






















Chronic diseases 0.185∗∗∗ 0.093∗∗∗ 0.108∗∗∗ 0.106∗∗∗
(0.015) (0.006) (0.029) (0.010)
Activity limitations 0.142∗∗∗ 0.087∗∗∗ 0.073∗∗∗ 0.045∗∗∗
(0.025) (0.010) (0.015) (0.007)
Age -0.027 -0.028∗ -0.019 0.006
(0.018) (0.012) (0.039) (0.020)
Age squared 0.000∗ 0.000∗∗ 0.000 -0.000
(0.000) (0.000) (0.000) (0.000)
Woman 0.155∗∗∗ 0.008 0.116 -0.002
(0.024) (0.014) (0.063) (0.031)
Educ. group (ref.: low)
Medium 0.022 0.018 0.023 -0.002
(0.030) (0.018) (0.075) (0.035)
High 0.066 -0.000 0.014 -0.071
(0.034) (0.021) (0.083) (0.047)
Retired 0.023 0.020 0.094 -0.005
(0.034) (0.019) (0.076) (0.035)
Married -0.033 -0.034∗ -0.003 0.036
(0.027) (0.017) (0.075) (0.031)
Equiv. hh income (cube root) 0.002 -0.002∗ 0.004 -0.001
(0.001) (0.001) (0.003) (0.002)
Wave 5 -0.046 -0.067∗∗∗ -0.145 -0.001
(0.027) (0.017) (0.074) (0.042)
Constant 1.835∗∗ 2.821∗∗∗ 1.590 2.320∗∗∗
(0.614) (0.419) (1.348) (0.704)
Country dummies Yes Yes Yes Yes
N 17,362 28,696 1,827 5,973
AIC 84,631 173,306 10,120 40,020
BIC 84,849 173,537 10,274 40,207
Note: “Unimpaired” refers to the sample that is objectively unimpaired, i.e. able to stand up from the chair and “Impaired”
refers to the sample that is objectively impaired, i.e. unable to stand up from the chair. The sample “No chronic dis. at w + 1”
includes those that have zero chronic diseases at wave w + 1, whereas “Chronic dis. at w + 1” refers to those that have one ore
more chronic diseases at wave w + 1. The dependent variable “doctor visits” is based on the annual number of doctor visits,
visits to emergency rooms and outpatient clinic visits at wave w + 1, i.e. Wave 4 or Wave 6. All explanatory variables are taken
from wave w, i.e. Wave 2 or Wave 5 respectively. The estimated coefficients are based on a negative binomial regression model




We conduct a range of robustness analyses to observe whether our results are sensitive to
model specifications and sample composition. These results are presented in Tables A.6
and A.7 in the Appendix along with the original model specification (Column 1).
5.1 Income
First, we utilise different income variables. We exchange the first imputed income variable
provided by SHARE with the second imputed income variable (Column 2), and we use in-
come that is not normalised with the cube root method but only equivalised (Column 3).
These adjustments have no effects on the results. We also replace income with wealth (Col-
umn 4), and the results remain robust.
5.2 Wave Specific Analyses
Second, we separate the sample by survey wave to explore whether the slight change in the
phrasing of the survey question about doctor visits in Wave 6 (Section 2.2.1), the restriction
of the chair stand test to those younger than 76 years in Wave 2 (Section 2.3), or the different
time gaps between w and w + 1 affect the results. The estimates in Table A.9 in the Appendix
reveal that the effect of health misperception on healthcare utilisation is slightly stronger at
Wave 5 than at Wave 2; however, the difference is not statistically significant according to a
Wald test.
5.3 Response Reliability
Third, we exclude anyone diagnosed with Alzheimer’s disease, dementia, or another seri-
ous memory impairment, as their survey answers might not be reliable (Column 5). The
results remain robust, perhaps because the number of individuals observations with severe
cognitive impairments in the survey is small.
5.4 Robustness to Further Controls
Finally, we conduct robustness analyses that are only possible for Wave 5, as they include
variables only collected in this wave (see Table A.8 in the Appendix). First, we analyse
whether differences in access to healthcare affect the number of doctor visits. For this, the
household respondent is asked “How easy is it to get to your general practitioner or the
nearest health center? Would you say it is very easy, easy, difficult or very difficult?” We
dichotomise the variable by comparing the first two and the last two possible answers and
add it to the model (Columns 2 and 5). The coefficients show, however, that the results do
not depend on access to healthcare. Second, we investigate whether the results are robust to
individuals purchasing supplementary health insurance. Although supplementary insur-
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ance increases healthcare utilisation (Moreira & Barros Pita 2010, Paccagnella et al. 2013),
we find no significant changes in our results (Column 6) when controlling for this variable.
5.5 Additional Measures of Health Perception
For the main analyses, health perception is operationalised based on tested and self-reported
ability to stand up from a chair. We also analyse whether the results hold for other health
dimensions, in particular health perception concerning cognition and walking ability.
5.5.1 Cognition
Similar to previous work, we use the difference between subjective and objective cognition
as an additional measure of health perception (Spitzer & Weber 2019). Objective cognition is
operationalised based on a memory test, which is conducted in Waves 4 to 6. In particular,
individuals are asked to recall a list of 10 words in any order within a minute.
Subjective cognition is based on the question “How would you rate your memory at the
present time?” which is answered on a Likert scale with the categories excellent, very good,
good, fair, and poor. Because the subjective cognition variable has more than 80% missing
values in Wave 6, we only utilise data from Waves 4 and 5. Hence, the estimates for cog-
nition are based on a different sample. For the main results presented in Section 4, health
perception from Waves 2 and 5 is matched with healthcare utilisation from Waves 4 and 6.
For the results for cognition, health perception from Waves 4 and 5 is matched with health-
care utilisation from Waves 5 and 6.
Defining cognitive impairment is not as straightforward as defining the ability to stand up
from a chair. Whereas the chair stand variables are binary and therefore clearly indicate
whether an individual is impaired, both the subjective and objective cognition variables are
categorical. Thus, we rely on previous literature to define the threshold marking cognitive
impairment. Participants are considered objectively impaired if they recall three words or
fewer (Grodstein et al. 2001, Purser et al. 2005). In addition, in robustness analyses, individ-
uals are considered impaired if they recall two words or fewer. Individuals are considered
subjectively impaired if they report having a fair or poor memory (Gardner et al. 2017).
Tables 6 provides regression results for this new specification of health perception. The re-
sults confirm our earlier findings. Individuals who underestimate their cognitive ability
at wave w are more likely to visit the doctor at wave w + 1 than individuals who achieve
concordance between objective and subjective measures of memory. By contrast, survey
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participants who overestimate their health have fewer annual doctor visits than those who
achieve concordance. Modifying the threshold for objective impairment from three to two
words changes the magnitude of the coefficient for overestimation but not its sign. The mag-
nitude of the coefficient for overestimation remains virtually identical.
5.5.2 Walking Ability
We also operationalise health perception based on walking ability. Objective walking abil-
ity is based on a walking speed test in which participants have to walk a distance of 2.5
m. Individuals are considered objectively impaired if their walking speed is 0.4 m per sec-
ond or slower. This threshold is in line with the previous literature (Jürges 2007, Steel et al.
2003). Because the test is only conducted in Waves 1 and 2, the analysis is restricted to those
waves (Börsch-Supan 2019a). The walking speed test is supposed to be conducted only for
individuals older than 75 years. However, the data set includes information for those 75 and
younger too. The variable has many missing values (∼90%) and thus needs to be handled
with caution.
Subjective walking impairment is based on the following question: “Please look at card
[. . . ]. We need to understand difficulties people may have with various activities because
of a health or physical problem. Please tell me whether you have any difficulty doing each
of the everyday activities on card [. . . ]. Exclude any difficulties that you expect to last less
than three months.” Participants are coded as having subjectively impaired walking ability
if they report difficulty walking 100 m.
When analysing health perception based on walking ability, we do not control for IADLs,
as the ability to walk across a room is itself considered an IADL. Also, the second imputed
income variable is used for this analysis, as the first one is not available in Wave 1. The
robustness analysis in Section 5.4 shows, however, that both variables produce the same re-
sults.
Results for the effects of health perception on the annual number of doctor visits based on
walking ability are provided in Table 7. The coefficients in Table 7 confirm once again that
individuals who underestimate their health have more annual doctor visits than those who
assess their health correctly. The results also show that those who overestimate their health
have fewer doctor visits. Thus, our results are robust to different specifications of health
perception.
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Table 6: Health perception based on cognition






















Chronic diseases 0.194∗∗∗ 0.143∗∗∗ 0.189∗∗∗ 0.147∗∗∗
(0.004) (0.009) (0.004) (0.014)
Activity limitations 0.114∗∗∗ 0.057∗∗∗ 0.106∗∗∗ 0.045∗∗∗
(0.005) (0.007) (0.005) (0.009)
Age 0.013 0.042∗ 0.017∗ 0.055
(0.009) (0.021) (0.008) (0.031)
Age squared -0.000 -0.000 -0.000 -0.000
(0.000) (0.000) (0.000) (0.000)
Woman 0.078∗∗∗ -0.003 0.072∗∗∗ -0.043
(0.011) (0.029) (0.011) (0.045)
Educ. group (ref.: low)
Medium 0.006 0.074∗ 0.010 0.013
(0.014) (0.037) (0.013) (0.056)
High 0.013 0.016 0.008 0.026
(0.016) (0.059) (0.016) (0.100)
Retired 0.033∗ -0.046 0.022 0.010
(0.016) (0.035) (0.015) (0.052)
Married -0.025 -0.035 -0.028∗ -0.030
(0.013) (0.031) (0.012) (0.045)
Equiv. hh income (cube root) -0.001∗ -0.000 -0.001∗ -0.003
(0.001) (0.002) (0.001) (0.002)
Wave 5 -0.037∗∗∗ -0.054∗ -0.036∗∗∗ -0.100∗
(0.010) (0.026) (0.010) (0.040)
Constant 1.086∗∗∗ 0.406 0.937∗∗ 0.245
(0.302) (0.750) (0.287) (1.114)
Control variables country Yes Yes Yes Yes
N 64,609 9,091 70,122 3,578
AIC 373,563 55,873 407,761 21,793
BIC 373,808 56,065 408,008 21,960
Note: In columns 1 and 2, individuals are considered objectively impaired if they recall 3 words or less (“3 words”), while in
columns 3 and 4 the cutoff is at 2 words or less (“2 words”). The dependent variable “doctor visits” is based on the annual
number of doctor visits, visits to emergency rooms and outpatient clinic visits at wave w + 1, i.e. Wave 5 or Wave 6. All
explanatory variables are taken from wave w, i.e. Wave 4 or Wave 5 respectively. The estimated coefficients are based on a
negative binomial regression model with mean dispersion. Standard errors are clustered at the household level and presented
in parentheses. * p<0.05, ** p<0.01, *** p<0.001
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Equiv. hh income (cube root) 2 -0.007 -0.023
(0.005) (0.013)








Note: The dependent variable “doctor visits” is based on the annual number of doctor visits, visits to emergency rooms and
outpatient clinic visits at wave w + 1, i.e. Wave 2 or Wave 4. All explanatory variables are taken from wave w, i.e. Wave 1
or Wave 2 respectively. The estimated coefficients are based on a negative binomial regression model with mean dispersion.
Standard errors are clustered at the household level and presented in parentheses. * p<0.05, ** p<0.01, *** p<0.001
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6 The Total Public Cost of Health Misperception
We perform a back-of-the-envelope calculation to estimate additional health expenditures
due to health misperception. The total cost of over- or underestimating health for the popu-
lation 50+ in the respective country Ct in year t is calculated as follows:
Cc,t = dc × mc × fc × pc,t (4)
where dc is the predicted cost per outpatient visit in 2010 Intl$ according to the World Health
Organisation for the respective country (World Health Organization 2011) and mc denotes
the marginal effect at means of over- or underestimating health on doctor visits (i.e., the dif-
ference in doctor visits between concordance and over- or underestimation according to our
estimates). The term fc denotes the fraction of individuals in the SHARE sample who over-
or underestimate their health, and pc,t is the population older than age 50 in the respective
country and year according to predictions from the Wittgenstein Centre for Demography
and Global Human Capital (2018).
We project that on average across the European Union, underestimation of the population
50+ will cost Intl$ 71 million in 2020 per country and increase to Intl$ 81 million by 2060.
Overestimation will result in negative healthcare costs of approximately Intl$ 37 million per
country in 2020 and Intl$ 45 million in 2060. Altogether, we project a net cost of Intl$ 34 mil-
lion per country in 2020. Note that although overestimation results in negative costs, these
are in the short run only. In the long run, overestimation may result in individuals skipping
timely screening and preventive care and lead to worse health, resulting in higher health-
care expenditures. Longer panel data will aid in evaluating the full cost of overestimation
in future work.
The costs of misperception are also projected separately for each country in our sample.
Figure 5 shows the total costs of underestimation in 2020, 2040, and 2060 – it is highest in
Germany, Italy, and France. When dividing the total cost of underestimation by the popu-
lation size, Germany, Denmark, and The Netherlands have the highest cost. Germany has a
high marginal effect at means of underestimating health on doctor visits mc along with a rel-
atively high fraction of individuals that underestimate their health fc. As a result, additional
outpatient visits due to underestimation are predicted to cost Germany Intl$ 503 million in
2020 and Intl$ 538 million in 2060. Denmark and The Netherlands have much lower fc, but
their high cost per outpatient visit dc along with large marginal effects mc result in high pub-
lic cost of underestimating health. Countries such as Poland and Czechia have much lower
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Figure 5: Projected total public cost of underestimating health for the population 50+
costs because approximately similar percentages report over- and underestimation and also
much lower consultation costs. Spain has the lowest predicted cost of underestimation per
capita. In total, it is Intl$ 59 million in 2020 and Intl$ 76 million in 2060. Table 8 shows pro-
jected misperception costs for all countries in 2020, 2040, and 2060.
7 Conclusion
We utilise rich longitudinal data from 15 European countries from SHARE to explore the
effects of health (mis)perception on healthcare utilisation. We categorise misperception as
arising due to overconfidence or underconfidence. Following the literature in psychology,
overconfidence is measured as overestimation of one’s health, whereas underconfidence is
defined analogously as underestimation of one’s own health. Healthcare utilisation is mea-
sured as the annual number of doctor visits. In addition, we assess the relationship between
misperception and OOP expenditures incurred by those who visit the doctor. Our results
based on count models and log-Gamma models suggest that individuals who underestimate
their health visit the doctor more often and have higher OOP expenditures than those who
assess their health correctly. By contrast, survey participants who overestimate their health
visit the doctor less often and have lower OOP payments.
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Table 8: Projected total cost of health misperception by country
Country Year Population 50+ Cost Cost underestimating Cost overestimating Balance
in 1,000 per visit in mio. 2010 Intl$ in mio. 2010 Intl$ in mio. 2010 Intl$
Austria 2020 3,725.3 46.8 22.1 -30.9 -8.8
2040 4,444.5 46.8 26.4 -36.9 -10.5
2060 4,726.9 46.8 28.1 -39.2 -11.2
Belgium 2020 4,554.0 44.4 31.8 -16.3 15.6
2040 5,416.9 44.4 37.9 -19.3 18.5
2060 5,922.0 44.4 41.4 -21.1 20.3
Czechia 2020 4,137.6 31.3 17.2 -24.1 -6.8
2040 5,038.8 31.3 21.0 -29.3 -8.3
2060 4,829.6 31.3 20.1 -28.1 -8.0
Denmark 2020 2,324.7 47.0 24.0 0.1 24.2
2040 2,569.4 47.0 26.5 0.2 26.7
2060 2,859.2 47.0 29.5 0.2 29.7
Estonia 2020 519.2 25.7 2.50 -1.7 0.9
2040 583.6 25.7 2.80 -1.9 1.0
2060 568.9 25.7 2.80 -1.8 0.9
France 2020 26,121.9 40.8 99.5 -50.1 49.4
2040 30,875.5 40.8 117.6 -59.2 58.4
2060 34,332.8 40.8 130.8 -65.8 65.0
Germany 2020 37,597.6 44.0 503.1 -83.5 419.6
2040 40,352.9 44.0 540.0 -89.6 450.3
2060 40,176.2 44.0 537.6 -89.2 448.4
Italy 2020 27,580.7 38.4 152.9 -35.8 117.1
2040 30,070.5 38.4 166.7 -39.0 127.7
2060 28,662.7 38.4 158.9 -37.2 121.7
Luxembourg 2020 214.5 89.5 1.7 -2.6 -0.9
2040 313.5 89.5 2.5 -3.7 -1.3
2060 386.3 89.5 3.0 -4.6 -1.6
Netherlands 2020 7,082.6 48.1 65.0 -47.0 18.0
2040 8,138.9 48.1 74.7 -54.0 20.7
2060 8,750.5 48.1 80.4 -58.1 22.3
Poland 2020 14,398.8 25.5 45.5 -70.2 -24.7
2040 17,587.8 25.5 55.5 -85.7 -30.2
2060 16,498.9 25.5 52.1 -80.4 -28.3
Slovenia 2020 880.7 32.6 4.9 -4.4 0.6
2040 1,048.1 32.6 5.9 -5.2 0.7
2060 1,026.1 32.6 5.8 -5.1 0.7
Spain 2020 19,709.0 37.8 59.0 -186.8 -127.7
2040 24,851.7 37.8 74.5 -235.5 -161.1
2060 25,235.6 37.8 75.6 -239.2 -163.6
Sweden 2020 3914.8 45.8 21.1 -9.2 11.9
2040 4703.5 45.8 25.4 -11.1 14.3
2060 5419.9 45.8 29.2 -12.7 16.5
Switzerland 2020 3,513.4 55.2 17.6 8.7 26.2
2040 4,516.4 55.2 22.6 11.1 33.7
2060 4,986.1 55.2 24.9 12.3 37.2
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Our results are robust to a range of sensitivity analyses with different model specifications,
sample compositions, estimation methods, and health dimensions. In addition, we account
for potential endogeneity by exploiting the panel structure of our data. Specifically, argu-
ments concerning individuals’ health perception improving as a result of frequent doctor
visits do not apply because we focus on current misperception and future doctor visits. De-
scriptive cross-tabulations show that individual characteristics such as education, illnesses,
age, retirement, supplementary insurance, and others do not matter for the relationship
between health misperception and healthcare utilisation; regressions controlling for these
variables confirm the stability of the results.
The main limitation of this study is related to panel attrition. Individuals who suffer from
diseases are less likely to participate in consecutive survey waves and thus are less likely to
be included in our sample. However, we address this limitation by running our analyses
separately by the number of diseases that a participant is suffering from and find no differ-
ence in the results between healthy and unhealthy participants, which suggests that panel
attrition is not a concern in our study. Future work could fruitfully explore the long-term
effects of health misperception on healthcare utilisation, for example, exploiting national
panel data collected over a longer period of time than SHARE data. Longer panels would
also allow for panel regressions and thus enable researchers to control for unobserved het-
erogeneity between observations.
The policy implications of our results are straightforward. First, addressing rising health
expenditures has been a top priority on policymakers’ agenda in many countries. Excessive
hospital admissions use more than 37 million bed days across the European Union every
year, significantly increasing public expenditures (OECD & European Commission 2018).
Containing sources of waste and inefficiency in healthcare on either the demand or supply
side is important in this regard. Our paper provides new insights, highlighting demand-side
misperception as a possible source of wasteful spending. Given our results, we perform a
back-of-the-envelope calculation of the costs of health misperception. (see Appendix 6 for
detail). We project that on average across the European Union, underestimation will cost
Intl$ 71 million in 2020 per country and increase to Intl$ 81 million by 2060. While overesti-
mating health reduces public healthcare expenditure in the short run, it is likely that in the
long run it will increase cost due to forgone preventive care.
Second, if individuals’ own perceptions of health are what drive healthcare demand beyond
actual health and other socioeconomic characteristics, then equipping them through person-
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alised or public health campaigns with the necessary tools and information to accurately
assess their health and determine when to seek healthcare is perhaps a valuable long-term
strategy for reducing unnecessary healthcare use. This is a particularly relevant measure
in countries with ageing populations that suffer from cognitive dissonance and thereby in-
creased health misperception (Brandtstädter & Greve 1994, Frieswijk et al. 2004, Henchoz
et al. 2008, Idler 1993, Spitzer & Weber 2019). Reaching out to those who overestimate their
health by providing information about the benefits of screening and preventive care might
also improve their health and thus prevent suffering and costs in the long run. Initiatives
to increase health literacy, such as the National Action Plan on Health Literacy, are already
in place in Germany (Vogt et al. 2018). Other countries can follow similar approaches to
evaluate health literacy levels and take strategic action to educate people.
Finally, wait time is often used as a non-price rationing measure in healthcare by policy-
makers (Barzel 1974, Iversen & Siciliani 2011). Identifying patients with health mispercep-
tion and reducing unnecessary visits to the doctor can have important implications for the
effectiveness of such rationing mechanisms. Not only will they free up physician capacity,
but they can also directly ensure timely care for other patients who are in need of urgent
intervention. Moreover, with the advent of artificial intelligence and technology, providing
individuals with the option to use online physician chatbots and telephone consultations
will further reduce the burden of unnecessary doctor visits due to misperception rather
than true health need.
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A Appendix
Table A.1: Crosstable mean doctor visits at w + 1 (weighted)
Health perception
Pos. concordance Underestimating Neg. concordance Overestimating Total
Mean doctor visits
No. chronic diseases at w
0 4.6 7.2 10.5 6.1 5.1
1 6.3 9.5 10.5 8.0 7.0
2 8.1 10.6 12.1 11.0 9.0
3 8.8 11.3 11.7 12.4 10.0
4 11.0 16.2 13.8 15.5 13.1
5 13.5 13.5 16.2 11.3 13.9
6 11.7 18.9 14.8 17.2 14.6
7 11.0 14.1 26.9 32.1 21.1
8 11.3 19.5 15.0 14.9 13.2
9 20.0 20.0
10 11.7 11.7
Total 6.2 10.1 11.9 8.6 7.2
No. activity limitations at w
0 6.0 9.0 11.1 7.8 6.5
1 8.3 10.3 10.8 9.8 9.3
2 9.8 14.0 11.6 13.9 12.0
3 11.7 11.5 11.9 15.1 12.2
4 10.2 31.1 11.6 12.3 15.5
5 7.8 11.7 12.3 18.6 12.8
6 5.2 11.4 14.7 12.4 13.2
7 8.8 15.8 13.4 15.6 13.8
8 4.7 8.6 15.3 9.8 13.6
9 7.6 9.6 20.2 11.5 18.9
10 30.0 20.5 6.7 19.4
11 9.1 9.8 6.0 9.7
12 6.2 16.6 30.6 16.4
13 5.5 8.6 14.5 98.0 10.3
Total 6.2 10.1 11.8 8.6 7.2
5-year age groups
50-54 5.2 10.6 11.7 6.8 5.9
55-59 5.4 10.9 13.8 7.2 6.4
60-64 6.0 9.1 10.5 8.9 6.8
65-69 6.8 9.5 13.5 9.4 7.7
70-74 7.7 10.8 10.9 9.1 8.5
75-79 8.1 9.0 12.0 12.1 9.1
80-84 8.0 11.4 10.4 9.0 9.0
85-89 6.4 9.4 12.8 9.3 8.7
90+ 5.5 7.8 9.2 13.9 9.0
Total 6.2 10.1 11.8 8.6 7.2
Gender
Men 6.0 10.0 11.8 8.1 6.7
Women 6.4 10.1 11.9 9.1 7.5
Total 6.2 10.1 11.8 8.6 7.2
Education
Low 6.6 10.1 11.8 9.2 7.7
Medium 6.2 9.7 12.1 8.2 7.0
High 5.7 10.8 11.3 7.5 6.4
Total 6.2 10.1 11.8 8.6 7.2
Note: Calibrated cross-sectional individual weights are applied.
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Table A.1, continued: Crosstable mean doctor visits at w + 1 (weighted)
Health perception
Pos. concordance Underestimating Neg. concordance Overestimating Total
Mean doctor visits
Is retired
No 5.5 10.2 11.6 7.9 6.4
Yes 7.0 10.0 11.9 9.3 7.9
Total 6.2 10.1 11.8 8.6 7.2
Is married
No 6.4 9.9 11.5 9.2 7.5
Yes 6.1 10.2 12.0 8.5 7.0
Total 6.2 10.1 11.8 8.7 7.2
Healt access
Not difficult 5.9 10.2 11.0 8.4 6.7
Difficult 6.5 10.0 12.0 10.6 8.3
Total 6.0 10.1 11.3 8.9 7.0
Supplementary insurance
No 6.1 10.4 11.7 9.7 7.3
Yes 5.7 9.4 10.6 7.1 6.4
Total 6.0 10.0 11.4 8.9 7.0
Has children
No 6.1 10.8 12.0 10.1 7.3
Yes 6.2 10.0 11.8 8.5 7.2
Total 6.2 10.1 11.8 8.7 7.2
Country
Austria 6.1 8.8 11.4 8.9 7.0
Germany 6.9 11.2 13.4 10.1 8.0
Sweden 3.8 5.7 10.6 5.4 4.3
Netherlands 5.0 7.4 9.8 8.6 5.5
Spain 5.2 8.6 10.2 7.5 6.2
Italy 7.3 13.1 13.8 10.2 8.6
France 5.6 7.7 9.3 6.7 6.1
Denmark 4.3 8.2 10.6 6.4 4.9
Switzerland 4.4 7.2 8.6 8.0 5.0
Belgium 7.0 10.3 16.4 9.5 8.0
Czechia 6.5 9.7 11.2 9.1 7.5
Poland 6.7 9.9 10.2 6.8 7.5
Luxembourg 7.7 10.5 17.3 12.1 9.0
Slovenia 4.5 7.4 9.0 7.5 5.5
Estonia 4.9 7.6 8.4 6.2 5.9
Total 6.2 10.1 11.8 8.6 7.2
Survey wave
Wave 2 6.5 10.1 12.6 8.3 7.4
Wave 5 6.0 10.0 11.4 8.9 7.0
Total 6.2 10.1 11.8 8.6 7.2
Note: Calibrated cross-sectional individual weights are applied.
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Table A.2: Crosstable mean OOP expenditures in Euros at w + 1 (weighted)
Health perception
Pos. concordance Underestimating Neg. concordance Overestimating Total
Mean OOP Mean OOP Mean OOP Mean OOP Mean OOP
No. chronic diseases at w
0 64.1 98.9 65.0 73.5 66.7
1 73.9 100.4 56.3 66.5 75.2
2 75.2 79.6 65.8 79.0 75.3
3 80.4 76.5 94.4 102.0 83.6
4 79.4 76.9 58.8 83.3 74.8
5 81.1 158.1 95.0 41.3 98.1
6 71.7 181.6 352.4 6.4 156.3
7 38.3 95.1 9.0 67.7 40.2
8 23.2 334.6 50.7 8.8 40.6
10 0.0 0.0
Total 70.8 92.4 74.6 74.6 73.6
No. activity limitations at w
0 71.8 90.5 75.7 73.7 73.5
1 62.5 96.5 72.9 61.7 71.3
2 53.6 50.9 52.3 108.2 60.7
3 44.8 140.5 160.1 103.2 121.3
4 35.6 86.4 34.0 34.6 46.9
5 38.1 57.9 75.4 57.3 64.6
6 9.8 54.0 90.8 42.6 73.3
7 0.0 123.1 18.7 527.8 60.6
8 34.2 0.0 47.2 59.3 39.9
9 163.4 19.0 15.6 0.0 16.7
10 0.0 219.9 0.0 197.9
11 352.6 28.2 0.0 60.5
12 289.9 46.6 8.6 100.2
13 2.2 298.1 141.1 240.2
Total 70.8 92.4 74.5 74.4 73.5
5-year age groups
50-54 60.8 147.3 57.4 46.8 65.8
55-59 67.4 80.9 72.5 103.9 71.0
60-64 70.6 78.8 86.0 68.4 71.8
65-69 73.9 80.6 110.8 89.8 77.6
70-74 89.7 99.7 86.3 58.6 88.1
75-79 76.2 96.6 102.2 81.5 82.7
80-84 67.5 74.3 42.5 86.9 67.1
85-89 48.3 70.0 45.3 52.9 51.5
90+ 49.0 15.4 10.8 47.2 35.1
Total 70.8 92.4 74.5 74.4 73.5
Gender
Men 74.5 70.4 62.2 60.9 72.7
Women 67.1 104.2 79.6 84.6 74.2
Total 70.8 92.4 74.5 74.4 73.5
Education
Low 62.0 89.3 78.5 64.3 66.8
Medium 71.1 92.0 71.0 70.6 73.3
High 85.4 108.5 55.7 120.8 88.4
Total 71.1 93.7 74.3 74.1 73.9
Note: Calibrated cross-sectional individual weights are applied.
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Table A.2, continued: Crosstable mean OOP expenditures in Euros at w + 1 (weighted)
Health perception
Pos. concordance Underestimating Neg. concordance Overestimating Total
Mean OOP Mean OOP Mean OOP Mean OOP Mean OOP
Is retired
No 64.8 101.1 54.4 81.8 68.5
Yes 77.0 87.4 88.7 70.0 78.5
Total 70.7 92.8 75.4 75.0 73.6
Is married
No 69.5 72.9 42.0 68.5 67.2
Yes 72.5 100.8 103.1 81.5 77.5
Total 71.6 90.8 74.8 76.2 74.1
Healt access
Not difficult 71.5 98.6 78.2 84.0 75.4
Difficult 67.7 81.4 66.7 43.8 66.6
Total 71.0 95.0 74.1 74.5 73.9
Supplementary insurance
No 70.5 101.1 73.0 75.8 74.3
Yes 71.2 76.6 80.2 71.3 72.2
Total 70.7 92.5 74.6 74.5 73.5
Has children
No 89.3 131.7 92.9 73.9 91.6
Yes 68.3 88.9 72.7 74.8 71.3
Total 70.8 92.8 75.0 74.7 73.6
Country
Austria 123.9 141.1 124.0 58.3 121.0
Germany 55.8 45.6 30.7 75.9 54.2
Sweden 67.9 75.2 75.6 66.9 68.9
Spain 10.1 33.4 64.2 16.5 18.0
Italy 139.7 270.5 135.8 132.5 149.2
France 28.6 37.3 27.2 29.8 29.5
Denmark 5.5 2.9 4.9 1.5 5.1
Switzerland 386.5 442.0 636.0 380.6 397.0
Belgium 90.6 183.0 155.2 90.9 105.1
Czechia 7.3 11.2 9.6 10.9 8.3
Luxembourg 171.3 209.6 292.1 206.8 185.3
Slovenia 13.9 20.2 9.9 2.8 13.2
Estonia 14.8 12.0 14.6 13.9 14.3
Total 70.8 92.4 74.5 74.4 73.5
Survey wave
Wave 5 70.8 92.4 74.5 74.4 73.5
Total 70.8 92.4 74.5 74.4 73.5
Note: Calibrated cross-sectional individual weights are applied.
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Table A.3: Crosstable health perception (weighted)
Health perception
Pos. concordance Underestimating Neg. concordance Overestimating Total
Row % 95% CI Row % 95% CI Row % 95% CI Row % 95% CI Row %
Objective impairment
Unimpaired (n=47,913) 88.0 [87.5,88.5] 12.0 [11.5,12.5] 0.0 0.0 100.0
Impaired (n=8,239) 0.0 0.0 38.3 [36.6,40.0] 61.7 [60.0,63.4] 100.0
Total (n=56,152) 74.3 [73.6,74.9] 10.1 [9.7,10.5] 6.0 [5.7,6.3] 9.6 [9.2,10.1] 100.0
Pearson: Uncorrected chi2(3) = 5.62e+04
Design-based F(2.77, 155429.77) = 7984.2277 Pr = 0.000
No. chronic diseases at w
0 (n=20,630) 82.1 [81.2,82.9] 5.7 [5.2,6.2] 3.1 [2.7,3.5] 9.1 [8.5,9.9] 100.0
1 (n=17,715) 76.2 [75.1,77.3] 10.2 [9.5,11.0] 4.4 [3.9,4.9] 9.2 [8.5,10.0] 100.0
2 (n=10,246) 67.8 [66.2,69.3] 13.9 [12.8,15.1] 8.2 [7.4,9.1] 10.1 [9.1,11.2] 100.0
3 (n=4,712) 60.4 [58.0,62.7] 16.2 [14.6,18.0] 11.7 [10.3,13.4] 11.6 [10.1,13.3] 100.0
4 (n=1,889) 48.2 [44.4,51.9] 20.4 [17.4,23.8] 20.1 [17.2,23.3] 11.4 [9.1,14.1] 100.0
5 (n=650) 39.5 [32.7,46.8] 25.7 [19.9,32.5] 24.1 [18.8,30.4] 10.7 [7.3,15.3] 100.0
6 (n=180) 39.9 [29.2,51.8] 16.3 [10.0,25.4] 28.5 [19.2,40.2] 15.2 [8.2,26.5] 100.0
7 (n=51) 22.1 [10.0,41.8] 19.9 [7.7,42.6] 53.0 [30.4,74.5] 5.0 [1.7,13.8] 100.0
8 (n=18) 50.9 [17.5,83.5] 3.7 [0.5,22.2] 36.6 [9.0,77.1] 8.8 [1.5,38.2] 100.0
9 (n=1) 100.0 0.0 0.0 0.0 100.0
10 (n=2) 100.0 0.0 0.0 0.0 100.0
Total (n=56,094) 74.3 [73.6,74.9] 10.1 [9.7,10.5] 6.0 [5.7,6.3] 9.6 [9.2,10.1] 100.0
Pearson: Uncorrected chi2(30) = 3717.8201
Design-based F(24.19, 1.36e+06) = 56.8893 Pr = 0.000
No. activity limitations at w
0 (n=47,381) 80.6 [80.0,81.2] 7.9 [7.5,8.3] 2.6 [2.3,2.8] 8.9 [8.5,9.4] 100.0
1 (n=4,717) 50.3 [47.9,52.7] 22.7 [20.8,24.9] 12.8 [11.3,14.5] 14.2 [12.5,16.0] 100.0
2 (n=1,683) 30.2 [26.6,34.0] 26.5 [23.2,30.0] 29.9 [26.3,33.8] 13.5 [11.1,16.4] 100.0
3 (n=851) 21.3 [16.7,26.6] 25.7 [21.2,30.7] 38.9 [33.5,44.6] 14.2 [10.4,19.0] 100.0
4 (n=485) 15.4 [10.4,22.2] 20.9 [14.4,29.3] 48.6 [40.4,56.8] 15.2 [10.9,20.7] 100.0
5 (n=340) 11.4 [6.9,18.2] 19.3 [13.3,27.2] 52.0 [43.0,60.9] 17.3 [11.0,26.1] 100.0
6 (n=224) 7.0 [2.5,18.1] 13.9 [8.4,22.1] 63.1 [51.7,73.2] 16.0 [9.3,26.1] 100.0
7 (n=159) 4.6 [1.6,12.6] 20.0 [10.5,34.7] 69.9 [55.8,81.1] 5.4 [2.2,12.9] 100.0
8 (n=93) 3.5 [0.8,13.2] 17.0 [7.8,33.0] 75.0 [59.6,85.9] 4.5 [1.8,10.8] 100.0
9 (n=71) 0.7 [0.2,3.4] 9.3 [3.0,25.7] 87.6 [71.8,95.1] 2.4 [0.4,12.7] 100.0
10 (n=42) 0.0 6.5 [0.9,34.1] 81.1 [58.6,92.9] 12.4 [4.0,32.4] 100.0
11 (n=27) 0.0 7.4 [1.7,26.5] 91.6 [73.2,97.7] 1.1 [0.1,7.6] 100.0
12 (n=26) 0.0 22.8 [8.5,48.3] 61.8 [36.9,81.7] 15.4 [4.2,43.0] 100.0
13 (n=49) 4.4 [0.9,19.7] 66.2 [49.3,79.8] 29.2 [16.8,45.7] 0.1 [0.0,0.8] 100.0
Total (n=56,148) 74.3 [73.6,74.9] 10.1 [9.7,10.5] 6.0 [5.7,6.3] 9.6 [9.2,10.1] 100.0
Pearson: Uncorrected chi2(39) = 1.49e+04
Design-based F(33.61, 1.89e+06) = 177.1679 Pr = 0.000
5-year age groups
50-54 (n=7,593) 81.7 [80.1,83.2] 7.0 [6.1,8.0] 2.8 [2.3,3.5] 8.5 [7.4,9.7] 100.0
55-59 (n=10,672) 78.6 [77.3,80.0] 8.7 [7.9,9.7] 4.0 [3.4,4.7] 8.6 [7.7,9.6] 100.0
60-64 (n=11,137) 77.0 [75.7,78.2] 10.6 [9.7,11.6] 4.2 [3.7,4.8] 8.2 [7.4,9.0] 100.0
65-69 (n=10,290) 73.6 [72.2,74.9] 10.7 [9.8,11.6] 5.4 [4.8,6.2] 10.3 [9.4,11.3] 100.0
70-74 (n=8,143) 68.7 [67.0,70.3] 12.5 [11.3,13.8] 8.3 [7.4,9.3] 10.5 [9.5,11.7] 100.0
75-79 (n=4,390) 63.7 [61.2,66.1] 13.9 [12.3,15.8] 11.8 [10.2,13.5] 10.6 [9.2,12.3] 100.0
80-84 (n=2,645) 55.7 [52.4,59.0] 13.2 [11.1,15.6] 16.5 [14.1,19.2] 14.6 [12.3,17.2] 100.0
85-89 (n=1,047) 47.4 [42.3,52.5] 13.8 [10.7,17.7] 20.6 [16.8,25.1] 18.1 [14.6,22.2] 100.0
90+ (n=235) 38.2 [28.3,49.1] 7.3 [4.1,12.6] 27.5 [18.9,38.2] 27.0 [18.4,37.8] 100.0
Total (n=56,152) 74.3 [73.6,74.9] 10.1 [9.7,10.5] 6.0 [5.7,6.3] 9.6 [9.2,10.1] 100.0
Pearson: Uncorrected chi2(24) = 2476.8374
Design-based F(22.74, 1.28e+06) = 37.9231 Pr = 0.000
Note: Calibrated cross-sectional individual weights are applied.
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Table A.3, continued: Crosstable health perception (weighted)
Health perception
Pos. concordance Underestimating Neg. concordance Overestimating Total
Row % 95% CI Row % 95% CI Row % 95% CI Row % 95% CI Row %
Gender
Men (n=24,503) 79.4 [78.5,80.2] 7.3 [6.8,7.8] 3.8 [3.5,4.2] 9.5 [8.9,10.2] 100.0
Women (n=31,649) 69.9 [69.0,70.7] 12.5 [11.9,13.2] 7.8 [7.3,8.3] 9.8 [9.2,10.4] 100.0
Total (n=56,152) 74.3 [73.6,74.9] 10.1 [9.7,10.5] 6.0 [5.7,6.3] 9.6 [9.2,10.1] 100.0
Pearson: Uncorrected chi2(3) = 922.0913
Design-based F(2.99, 167664.12) = 107.2160 Pr = 0.000
Education
Low (n=21,346) 68.2 [67.2,69.2] 11.0 [10.4,11.7] 8.8 [8.3,9.5] 12.0 [11.3,12.7] 100.0
Medium (n=21,228) 76.1 [75.0,77.1] 10.3 [9.6,11.0] 4.8 [4.3,5.3] 8.8 [8.1,9.6] 100.0
High (n=12,833) 83.2 [82.0,84.3] 7.8 [7.1,8.6] 2.5 [2.1,3.0] 6.5 [5.7,7.3] 100.0
Total (n=55,407) 74.3 [73.7,74.9] 10.1 [9.7,10.5] 6.0 [5.7,6.3] 9.6 [9.2,10.1] 100.0
Pearson: Uncorrected chi2(6) = 1177.9308
Design-based F(5.94, 329109.56) = 68.3745 Pr = 0.000
Is retired
No (n=25,298) 77.6 [76.7,78.5] 8.7 [8.2,9.3] 4.8 [4.4,5.3] 8.8 [8.2,9.5] 100.0
Yes (n=30,601) 71.0 [70.1,71.8] 11.6 [11.0,12.2] 7.0 [6.6,7.5] 10.5 [9.9,11.1] 100.0
Total (n=55,899) 74.4 [73.8,75.0] 10.1 [9.7,10.5] 5.9 [5.6,6.2] 9.6 [9.2,10.1] 100.0
Pearson: Uncorrected chi2(3) = 344.7396
Design-based F(2.99, 167064.47) = 39.5269 Pr = 0.000
Is married
No (n=14,874) 69.8 [68.5,71.1] 11.4 [10.6,12.4] 8.1 [7.4,8.9] 10.7 [9.8,11.6] 100.0
Yes (n=39,474) 76.1 [75.4,76.7] 9.6 [9.2,10.1] 5.1 [4.8,5.5] 9.2 [8.8,9.7] 100.0
Total (n=54,348) 74.2 [73.5,74.8] 10.2 [9.7,10.6] 6.0 [5.7,6.3] 9.7 [9.2,10.1] 100.0
Pearson: Uncorrected chi2(3) = 290.4041
Design-based F(2.98, 162037.55) = 30.4726 Pr = 0.000
Healt access
Not difficult (n=32,586) 78.2 [77.4,78.9] 9.7 [9.2,10.3] 5.0 [4.6,5.4] 7.2 [6.7,7.7] 100.0
Difficult (n=6,341) 60.8 [58.5,63.0] 13.1 [11.7,14.7] 14.6 [13.1,16.4] 11.5 [10.1,13.0] 100.0
Total (n=38,927) 75.3 [74.6,76.1] 10.3 [9.7,10.8] 6.5 [6.1,7.0] 7.9 [7.4,8.4] 100.0
Pearson: Uncorrected chi2(3) = 1158.8844
Design-based F(2.99, 116441.54) = 116.8392 Pr = 0.000
Note: Calibrated cross-sectional individual weights are applied.
46
Table A.3, continued: Crosstable health perception (weighted)
Health perception
Pos. concordance Underestimating Neg. concordance Overestimating Total
Row % 95% CI Row % 95% CI Row % 95% CI Row % 95% CI Row %
Supplementary insurance
No (n=26,149) 73.0 [72.1,74.0] 10.3 [9.6,10.9] 7.8 [7.3,8.4] 8.9 [8.3,9.5] 100.0
Yes (n=15,280) 78.8 [77.6,79.9] 10.4 [9.6,11.2] 4.4 [3.8,4.9] 6.5 [5.9,7.2] 100.0
Total (n=41,429) 75.1 [74.4,75.8] 10.3 [9.8,10.8] 6.6 [6.2,7.0] 8.0 [7.6,8.5] 100.0
Pearson: Uncorrected chi2(3) = 282.3894
Design-based F(2.99, 123937.16) = 31.5801 Pr = 0.000
Has children
No (n=5,121) 74.2 [72.1,76.1] 9.3 [8.0,10.7] 6.0 [5.0,7.2] 10.5 [9.2,12.1] 100.0
Yes (n=50,336) 74.2 [73.6,74.9] 10.2 [9.8,10.7] 6.0 [5.7,6.3] 9.5 [9.1,10.0] 100.0
Total (n=55,457) 74.2 [73.6,74.8] 10.1 [9.7,10.6] 6.0 [5.7,6.3] 9.6 [9.2,10.1] 100.0
Pearson: Uncorrected chi2(3) = 10.8682
Design-based F(2.99, 165995.64) = 1.0866 Pr = 0.353
Country
Austria (n=3,241) 72.7 [70.7,74.6] 11.5 [10.1,12.9] 7.1 [6.1,8.3] 8.7 [7.5,10.0] 100.0
Germany (n=5,222) 75.8 [74.4,77.2] 12.7 [11.6,13.8] 5.1 [4.4,5.8] 6.4 [5.7,7.2] 100.0
Sweden (n=4,722) 80.3 [78.9,81.6] 9.6 [8.6,10.5] 3.9 [3.3,4.7] 6.2 [5.4,7.1] 100.0
Netherlands (n=1,376) 84.2 [82.1,86.2] 8.5 [7.1,10.1] 2.9 [2.1,4.0] 4.4 [3.4,5.7] 100.0
Spain (n=5,384) 71.7 [69.8,73.5] 8.6 [7.5,9.7] 8.7 [7.7,9.8] 11.0 [9.8,12.4] 100.0
Italy (n=4,868) 70.3 [68.7,71.8] 8.3 [7.4,9.2] 6.9 [6.1,7.8] 14.5 [13.4,15.8] 100.0
France (n=4,311) 76.6 [75.1,78.1] 9.0 [8.1,10.0] 4.5 [3.8,5.2] 9.9 [8.8,11.0] 100.0
Denmark (n=4,475) 86.1 [85.0,87.1] 7.9 [7.1,8.8] 2.6 [2.2,3.2] 3.4 [2.8,4.0] 100.0
Switzerland (n=3,344) 83.9 [82.5,85.2] 7.4 [6.6,8.4] 2.6 [2.1,3.3] 6.1 [5.2,7.0] 100.0
Belgium (n=5,599) 77.0 [75.7,78.2] 11.5 [10.6,12.5] 5.2 [4.6,5.9] 6.4 [5.6,7.1] 100.0
Czechia (n=5,147) 71.6 [69.6,73.5] 10.2 [9.1,11.5] 8.3 [7.3,9.5] 9.9 [8.5,11.4] 100.0
Poland (n=1,222) 61.4 [58.5,64.3] 14.1 [12.2,16.3] 9.7 [8.1,11.6] 14.7 [12.7,17.0] 100.0
Luxembourg (n=1,013) 73.4 [70.3,76.2] 12.5 [10.5,14.8] 6.3 [4.9,8.2] 7.8 [6.1,9.9] 100.0
Slovenia (n=2,222) 72.0 [69.8,74.2] 10.8 [9.5,12.4] 7.3 [6.2,8.6] 9.9 [8.4,11.5] 100.0
Estonia (n=4,006) 64.9 [63.3,66.5] 13.8 [12.7,15.0] 12.6 [11.5,13.7] 8.7 [7.8,9.7] 100.0
Total (n=56,152) 74.3 [73.6,74.9] 10.1 [9.7,10.5] 6.0 [5.7,6.3] 9.6 [9.2,10.1] 100.0
Pearson: Uncorrected chi2(42) = 1357.8340
Design-based F(20.44, 1.15e+06) = 26.8724 Pr = 0.000
Survey wave
Wave 2 (n=14,623) 73.1 [72.0,74.1] 9.9 [9.2,10.6] 5.1 [4.7,5.7] 11.9 [11.2,12.7] 100.0
Wave 5 (n=41,529) 75.1 [74.3,75.8] 10.3 [9.8,10.8] 6.6 [6.2,7.0] 8.0 [7.6,8.5] 100.0
Total (n=56,152) 74.3 [73.6,74.9] 10.1 [9.7,10.5] 6.0 [5.7,6.3] 9.6 [9.2,10.1] 100.0
Pearson: Uncorrected chi2(3) = 272.0734
Design-based F(3.00, 168272.56) = 30.3672 Pr = 0.000
Note: Calibrated cross-sectional individual weights are applied.
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Table A.4: Underestimating health and annual number of doctor visits at w + 1 by country
(1) (2) (3) (4) (5) (6) (7) (8)
Austria Belgium Czechia Denmark Estonia France Germany Italy
Health perception (ref.: concordance)
Underestimating 0.157∗ 0.180∗∗∗ 0.171∗∗∗ 0.510∗∗∗ 0.241∗∗∗ 0.173∗∗∗ 0.306∗∗∗ 0.211∗∗∗
(0.063) (0.051) (0.045) (0.090) (0.072) (0.048) (0.053) (0.063)
Chronic diseases 0.166∗∗∗ 0.171∗∗∗ 0.181∗∗∗ 0.206∗∗∗ 0.226∗∗∗ 0.177∗∗∗ 0.188∗∗∗ 0.218∗∗∗
(0.021) (0.016) (0.014) (0.019) (0.021) (0.014) (0.016) (0.018)
Activity limitations 0.072∗ 0.163∗∗∗ 0.060∗ 0.075∗ 0.128∗∗∗ 0.045∗∗ 0.132∗∗∗ 0.030
(0.032) (0.029) (0.028) (0.036) (0.026) (0.017) (0.036) (0.017)
Age 0.006 -0.035 0.036 0.004 0.006 -0.048 -0.045 0.081∗
(0.041) (0.028) (0.035) (0.036) (0.040) (0.029) (0.028) (0.037)
Age squared 0.000 0.000 -0.000 -0.000 -0.000 0.000 0.000 -0.000
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Woman 0.094 0.134∗∗∗ 0.054 0.003 -0.061 0.069 0.058 0.161∗∗∗
(0.053) (0.038) (0.035) (0.047) (0.049) (0.036) (0.036) (0.042)
Educ. group (ref.: low)
Medium 0.035 -0.051 0.012 -0.007 0.033 -0.035 0.040 -0.047
(0.063) (0.047) (0.037) (0.071) (0.058) (0.041) (0.060) (0.057)
High 0.050 -0.039 0.014 -0.016 0.073 -0.001 0.015 -0.178∗
(0.070) (0.045) (0.052) (0.073) (0.074) (0.052) (0.065) (0.084)
Retired 0.074 0.056 -0.025 0.045 0.038 0.001 0.097 -0.003
(0.065) (0.046) (0.067) (0.065) (0.067) (0.049) (0.054) (0.060)
Married -0.053 -0.082 0.065 -0.120∗ -0.042 -0.016 -0.013 0.007
(0.053) (0.042) (0.038) (0.050) (0.050) (0.039) (0.044) (0.059)
Equiv. hh income (cube root) -0.000 -0.001 -0.002 -0.004 0.011 -0.002 -0.001 -0.002
(0.002) (0.002) (0.003) (0.003) (0.007) (0.002) (0.002) (0.002)
Constant 0.867 2.702∗∗ 0.172 1.307 0.893 3.183∗∗ 3.161∗∗∗ -1.246
(1.392) (0.925) (1.161) (1.249) (1.334) (0.969) (0.908) (1.214)
Wave dummies Yes Yes Yes Yes Yes Yes Yes Yes
N 2,593 4,666 3,991 4,082 3,048 3,530 4,587 3,757
AIC 15,395 28,098 23,833 21,083 16,761 19,215 27,479 23,323
BIC 15,478 28,188 23,921 21,171 16,839 19,301 27,570 23,410
Note: The coefficients are based on the sample that is objectively unimpaired, i.e. able to stand up from the chair. The dependent variable “doctor visits” is based on the annual number of
doctor visits, visits to emergency rooms and outpatient clinic visits at wave w + 1, i.e. Wave 4 or Wave 6. All explanatory variables are taken from wave w, i.e. Wave 2 or Wave 5 respectively.
The estimated coefficients are based on a negative binomial regression model with mean dispersion. Standard errors are clustered at the household level and presented in parentheses. *
p<0.05, ** p<0.01, *** p<0.001
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Table A.4, continued: Underestimating health and annual number of doctor visits at w + 1 by country
(1) (2) (3) (4) (5) (6) (7)
Luxembourg Netherlands Poland Slovenia Spain Sweden Switzerland
Health perception (ref.: concordance)
Underestimating 0.088 0.370∗ 0.120 0.302∗∗∗ 0.172∗∗ 0.277∗∗∗ 0.240∗∗
(0.105) (0.174) (0.079) (0.079) (0.057) (0.066) (0.079)
Chronic diseases 0.107∗∗∗ 0.162∗∗∗ 0.255∗∗∗ 0.222∗∗∗ 0.181∗∗∗ 0.123∗∗∗ 0.204∗∗∗
(0.031) (0.043) (0.026) (0.028) (0.018) (0.022) (0.025)
Activity limitations 0.266∗∗∗ 0.028 0.045 -0.002 0.038 0.159∗∗∗ 0.222∗∗
(0.063) (0.071) (0.029) (0.051) (0.023) (0.040) (0.072)
Age -0.098 -0.003 0.149 0.010 0.007 0.026 0.026
(0.073) (0.129) (0.103) (0.058) (0.034) (0.040) (0.046)
Age squared 0.001 0.000 -0.001 0.000 0.000 -0.000 -0.000
(0.001) (0.001) (0.001) (0.000) (0.000) (0.000) (0.000)
Woman 0.091 -0.054 0.038 -0.076 0.085 -0.087 -0.011
(0.093) (0.086) (0.071) (0.062) (0.046) (0.050) (0.057)
Educ. group (ref.: low)
Medium 0.228∗ -0.253∗ 0.035 0.009 -0.043 0.103 0.007
(0.098) (0.099) (0.074) (0.069) (0.075) (0.068) (0.076)
High -0.143 0.004 -0.045 -0.053 0.049 0.080 0.031
(0.113) (0.112) (0.105) (0.090) (0.079) (0.069) (0.094)
Retired 0.044 -0.236∗ 0.086 0.019 0.040 0.082 0.153∗
(0.104) (0.102) (0.086) (0.088) (0.050) (0.090) (0.077)
Married -0.161 -0.003 0.131 0.054 0.075 -0.065 -0.147∗
(0.111) (0.108) (0.094) (0.072) (0.051) (0.061) (0.070)
Equiv. hh income (cube root) 0.006 -0.001 0.005 0.004 -0.001 -0.008 -0.003
(0.003) (0.005) (0.007) (0.005) (0.003) (0.005) (0.002)
Constant 5.093∗ 1.545 -3.495 0.431 0.966 -0.038 0.578
(2.391) (4.046) (3.186) (1.906) (1.160) (1.388) (1.575)
Wave dummies Yes Yes Yes Yes Yes Yes Yes
N 878 1,196 911 1,810 3,948 4,130 2,940
AIC 5,424 6,581 5,525 9,590 21,252 20,692 15,472
BIC 5,486 6,647 5,588 9,661 21,340 20,780 15,556
Note: The coefficients are based on the sample that is objectively unimpaired, i.e. able to stand up from the chair. The dependent variable “doctor visits” is based on the annual number of
doctor visits, visits to emergency rooms and outpatient clinic visits at wave w + 1, i.e. Wave 4 or Wave 6. All explanatory variables are taken from wave w, i.e. Wave 2 or Wave 5 respectively.
The estimated coefficients are based on a negative binomial regression model with mean dispersion. Standard errors are clustered at the household level and presented in parentheses. *
p<0.05, ** p<0.01, *** p<0.001
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Table A.5: Overestimating health and annual number of doctor visits at w + 1 by country
(1) (2) (3) (4) (5) (6) (7) (8)
Austria Belgium Czechia Denmark Estonia France Germany Italy
Health perception (ref.: concordance)
Overestimating -0.205 -0.112 -0.190∗∗ 0.006 -0.192∗∗ -0.062 -0.068 -0.022
(0.122) (0.084) (0.060) (0.157) (0.074) (0.085) (0.106) (0.090)
Chronic diseases 0.183∗∗∗ 0.142∗∗∗ 0.138∗∗∗ 0.203∗∗∗ 0.162∗∗∗ 0.058 0.123∗∗∗ 0.237∗∗∗
(0.040) (0.027) (0.022) (0.038) (0.025) (0.029) (0.034) (0.031)
Activity limitations 0.044 0.110∗∗∗ 0.022 0.099∗∗ 0.022 0.073∗∗ 0.049∗ 0.048∗∗
(0.024) (0.021) (0.016) (0.034) (0.021) (0.027) (0.022) (0.015)
Age 0.034 0.013 0.087∗ -0.185∗ 0.146∗ -0.010 -0.110 0.065
(0.074) (0.055) (0.042) (0.081) (0.060) (0.056) (0.073) (0.051)
Age squared -0.000 -0.000 -0.001∗ 0.001∗ -0.001∗∗ 0.000 0.001 -0.000
(0.001) (0.000) (0.000) (0.001) (0.000) (0.000) (0.001) (0.000)
Woman -0.085 0.151 -0.077 0.176 -0.043 0.016 0.014 0.210∗∗
(0.135) (0.087) (0.064) (0.154) (0.073) (0.083) (0.109) (0.073)
Educ. group (ref.: low)
Medium -0.185 -0.128 0.013 0.093 0.018 0.013 0.107 -0.149
(0.121) (0.100) (0.060) (0.194) (0.082) (0.093) (0.154) (0.109)
High 0.139 -0.110 0.066 -0.210 -0.091 0.083 -0.047 0.014
(0.171) (0.094) (0.120) (0.181) (0.104) (0.126) (0.175) (0.146)
Retired 0.061 -0.017 -0.098 -0.014 -0.109 0.100 0.306∗ -0.008
(0.141) (0.097) (0.101) (0.193) (0.121) (0.100) (0.132) (0.082)
Married -0.004 0.150 0.055 0.171 0.185∗∗ 0.001 -0.014 -0.065
(0.115) (0.083) (0.064) (0.158) (0.072) (0.094) (0.123) (0.084)
Equiv. hh income (cube root) -0.004 -0.013∗∗ -0.004 -0.015 0.004 -0.001 0.005 -0.001
(0.005) (0.004) (0.004) (0.009) (0.006) (0.005) (0.005) (0.003)
Constant 1.124 1.677 -0.796 8.084∗∗ -3.010 2.221 5.848∗ -0.460
(2.636) (1.944) (1.450) (2.863) (2.078) (1.986) (2.437) (1.746)
Wave dummies Yes Yes Yes Yes Yes Yes Yes Yes
N 423 591 964 236 834 554 532 950
AIC 2,857 4,062 6,325 1,471 5,144 3,355 3,734 6,501
BIC 2,913 4,124 6,393 1,520 5,205 3,416 3,793 6,569
Note: The coefficients are based on the sample that is objectively impaired, i.e. unable to stand up from the chair. The dependent variable “doctor visits” is based on the annual number of
doctor visits, visits to emergency rooms and outpatient clinic visits at wave w + 1, i.e. Wave 4 or Wave 6. All explanatory variables are taken from wave w, i.e. Wave 2 or Wave 5 respectively.
The estimated coefficients are based on a negative binomial regression model with mean dispersion. Standard errors are clustered at the household level and presented in parentheses. *
p<0.05, ** p<0.01, *** p<0.001
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Table A.5, continued: Overestimating health and annual number of doctor visits at w + 1 by country
(1) (2) (3) (4) (5) (6) (7)
Luxembourg Netherlands Poland Slovenia Spain Sweden Switzerland
Health perception (ref.: concordance)
Overestimating -0.134 -0.346 -0.160 -0.207 -0.298∗∗∗ -0.135 0.096
(0.166) (0.271) (0.112) (0.113) (0.071) (0.166) (0.149)
Chronic diseases 0.112∗ 0.274∗∗ 0.136∗∗∗ 0.073∗ 0.142∗∗∗ 0.107∗∗ 0.150∗
(0.055) (0.102) (0.035) (0.035) (0.024) (0.040) (0.072)
Activity limitations 0.122∗∗∗ -0.065 0.054 -0.019 0.017 0.066∗ 0.118∗
(0.032) (0.058) (0.034) (0.021) (0.018) (0.031) (0.055)
Age 0.373∗∗ 0.603 0.072 0.070 -0.006 -0.155 0.166
(0.130) (0.345) (0.130) (0.076) (0.043) (0.115) (0.104)
Age squared -0.003∗∗ -0.005 -0.001 -0.001 0.000 0.001 -0.001
(0.001) (0.003) (0.001) (0.001) (0.000) (0.001) (0.001)
Woman -0.057 -0.059 -0.138 0.221∗ -0.125 -0.003 -0.001
(0.180) (0.242) (0.117) (0.094) (0.087) (0.154) (0.157)
Educ. group (ref.: low)
Medium 0.164 0.476 0.005 -0.083 -0.130 0.290 -0.018
(0.168) (0.324) (0.110) (0.105) (0.149) (0.217) (0.192)
High -0.428 -0.294 0.238 -0.409∗ -0.179 -0.197 -0.146
(0.409) (0.274) (0.240) (0.184) (0.184) (0.161) (0.227)
Retired -0.630∗∗ -0.329 0.183 0.134 0.049 0.496∗ 0.122
(0.214) (0.331) (0.122) (0.121) (0.079) (0.238) (0.225)
Married -0.083 -0.179 0.044 -0.044 0.056 -0.032 -0.302
(0.173) (0.274) (0.118) (0.115) (0.087) (0.177) (0.175)
Equiv. hh income (cube root) -0.011∗∗ 0.030∗ -0.003 0.002 -0.001 0.005 -0.004
(0.004) (0.012) (0.012) (0.008) (0.005) (0.010) (0.005)
Constant -9.187∗ -17.679 -0.059 0.432 2.510 6.492 -4.023
(4.345) (10.819) (4.064) (2.540) (1.525) (4.365) (3.622)
Wave dummies Yes Yes Yes Yes Yes Yes Yes
N 120 87 305 377 1,151 417 260
AIC 868 587 1,928 2,315 7,028 2,430 1,652
BIC 904 619 1,976 2,366 7,099 2,486 1,702
Note: The coefficients are based on the sample that is objectively impaired, i.e. unable to stand up from the chair. The dependent variable “doctor visits” is based on the annual number of
doctor visits, visits to emergency rooms and outpatient clinic visits at wave w + 1, i.e. Wave 4 or Wave 6. All explanatory variables are taken from wave w, i.e. Wave 2 or Wave 5 respectively.
The estimated coefficients are based on a negative binomial regression model with mean dispersion. Standard errors are clustered at the household level and presented in parentheses. *
p<0.05, ** p<0.01, *** p<0.001
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Table A.6: Robustness analyses for annual doctor visits of the unimpaired sample
(1) (2) (3) (4) (5)
Main Income 1 Income 2 Wealth Alzheimer dropped
Health perception (ref.: concordance)
Underestimating 0.244∗∗∗ 0.244∗∗∗ 0.244∗∗∗ 0.240∗∗∗ 0.243∗∗∗
(0.018) (0.018) (0.018) (0.018) (0.019)
Chronic diseases 0.181∗∗∗ 0.181∗∗∗ 0.181∗∗∗ 0.179∗∗∗ 0.182∗∗∗
(0.005) (0.005) (0.005) (0.005) (0.005)
Activity limitations 0.096∗∗∗ 0.096∗∗∗ 0.096∗∗∗ 0.095∗∗∗ 0.097∗∗∗
(0.010) (0.010) (0.010) (0.010) (0.010)
Age -0.001 -0.000 -0.001 0.004 -0.001
(0.011) (0.011) (0.011) (0.011) (0.011)
Age squared 0.000 0.000 0.000 0.000 0.000
(0.000) (0.000) (0.000) (0.000) (0.000)
Woman 0.042∗∗∗ 0.042∗∗∗ 0.042∗∗∗ 0.042∗∗∗ 0.042∗∗∗
(0.013) (0.013) (0.013) (0.013) (0.013)
Educ. group (ref.: low)
Medium 0.006 0.008 0.005 0.018 0.007
(0.016) (0.016) (0.016) (0.016) (0.016)
High -0.003 0.002 -0.004 0.020 -0.003
(0.018) (0.019) (0.018) (0.019) (0.019)
Retired 0.029 0.031 0.029 0.030 0.028
(0.017) (0.017) (0.017) (0.017) (0.017)
Married -0.034∗ -0.031∗ -0.035∗ -0.018 -0.035∗
(0.015) (0.015) (0.015) (0.015) (0.015)
Equiv. hh income (cube root) -0.001 -0.001
(0.001) (0.001)
Wave 5 -0.089∗∗∗ -0.085∗∗∗ -0.089∗∗∗ -0.092∗∗∗ -0.089∗∗∗
(0.015) (0.015) (0.015) (0.015) (0.015)
Equiv. hh income (cube root) 2 -0.002
(0.001)
Equiv. hh income not normalised -0.000
(0.000)









Constant 1.507∗∗∗ 1.499∗∗∗ 1.485∗∗∗ 1.381∗∗∗ 1.491∗∗∗
(0.356) (0.357) (0.356) (0.356) (0.358)
Country dummies Yes Yes Yes Yes Yes
N 46,067 46,067 46,067 46,067 45,917
AIC 260,957 260,954 260,958 260,875 259,975
BIC 261,202 261,199 261,203 261,146 260,219
Note: The coefficients are based on the sample that is objectively unimpaired, i.e. able to stand up from the chair. The
dependent variable “doctor visits” is based on the annual number of doctor visits, visits to emergency rooms and outpatient
clinic visits at wave w + 1, i.e. Wave 4 or Wave 6. All explanatory variables are taken from wave w, i.e. Wave 2 or Wave 5
respectively. The estimated coefficients are based on a negative binomial regression model with mean dispersion. Standard
errors are clustered at the household level and presented in parentheses. * p<0.05, ** p<0.01, *** p<0.001
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Table A.7: Robustness analyses for annual doctor visits of the impaired sample
(1) (2) (3) (4) (5)
Main Income 1 Income 2 Wealth Alzheimer dropped
Health perception (ref.: concordance)
Overestimating -0.146∗∗∗ -0.146∗∗∗ -0.146∗∗∗ -0.145∗∗∗ -0.144∗∗∗
(0.029) (0.029) (0.029) (0.029) (0.029)
Chronic diseases 0.149∗∗∗ 0.149∗∗∗ 0.149∗∗∗ 0.146∗∗∗ 0.152∗∗∗
(0.009) (0.009) (0.009) (0.009) (0.009)
Activity limitations 0.048∗∗∗ 0.048∗∗∗ 0.048∗∗∗ 0.047∗∗∗ 0.049∗∗∗
(0.007) (0.007) (0.007) (0.007) (0.007)
Age 0.021 0.022 0.021 0.023 0.024
(0.018) (0.018) (0.018) (0.019) (0.018)
Age squared -0.000 -0.000 -0.000 -0.000 -0.000
(0.000) (0.000) (0.000) (0.000) (0.000)
Woman 0.014 0.014 0.014 0.015 0.009
(0.028) (0.028) (0.028) (0.028) (0.028)
Educ. group (ref.: low)
Medium -0.006 -0.005 -0.007 0.006 -0.007
(0.033) (0.033) (0.033) (0.033) (0.033)
High -0.087∗ -0.084∗ -0.088∗ -0.069 -0.084∗
(0.042) (0.043) (0.042) (0.043) (0.042)
Retired 0.014 0.016 0.014 0.019 0.011
(0.033) (0.033) (0.033) (0.033) (0.033)
Married 0.019 0.023 0.019 0.034 0.012
(0.030) (0.031) (0.030) (0.030) (0.030)
Equiv. hh income (cube root) -0.001 -0.001
(0.002) (0.002)
Wave 5 -0.046 -0.042 -0.046 -0.047 -0.045
(0.038) (0.038) (0.038) (0.038) (0.038)
Equiv. hh income (cube root) 2 -0.001
(0.002)
Equiv. hh income not normalised -0.000
(0.000)









Constant 1.434∗ 1.434∗ 1.421∗ 1.382∗ 1.338∗
(0.646) (0.645) (0.643) (0.645) (0.645)
Country dummies Yes Yes Yes Yes Yes
N 7,801 7,801 7,801 7,801 7,709
AIC 50,545 50,544 50,545 50,534 49,893
BIC 50,740 50,739 50,740 50,749 50,088
Note: The coefficients are based on the sample that is objectively impaired, i.e. unable to stand up from the chair. The
dependent variable “doctor visits” is based on the annual number of doctor visits, visits to emergency rooms and outpatient
clinic visits at wave w + 1, i.e. Wave 4 or Wave 6. All explanatory variables are taken from wave w, i.e. Wave 2 or Wave 5
respectively. The estimated coefficients are based on a negative binomial regression model with mean dispersion. Standard
errors are clustered at the household level and presented in parentheses. * p<0.05, ** p<0.01, *** p<0.001
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Table A.8: Robustness analyses for Wave 5



















Health perception (ref.: concordance)
Underestimating 0.259∗∗∗ 0.261∗∗∗ 0.259∗∗∗
(0.021) (0.022) (0.021)
Chronic diseases 0.176∗∗∗ 0.173∗∗∗ 0.176∗∗∗ 0.143∗∗∗ 0.140∗∗∗ 0.143∗∗∗
(0.006) (0.006) (0.006) (0.010) (0.011) (0.010)
Activity limitations 0.093∗∗∗ 0.095∗∗∗ 0.094∗∗∗ 0.048∗∗∗ 0.052∗∗∗ 0.049∗∗∗
(0.011) (0.011) (0.011) (0.007) (0.007) (0.007)
Age 0.004 0.006 0.003 0.028 0.026 0.028
(0.012) (0.012) (0.012) (0.021) (0.022) (0.021)
Age squared 0.000 0.000 0.000 -0.000 -0.000 -0.000
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000)
Woman 0.038∗∗ 0.038∗∗ 0.039∗∗ -0.036 -0.034 -0.036
(0.014) (0.015) (0.014) (0.032) (0.033) (0.032)
Educ. group (ref.: low)
Medium 0.022 0.026 0.022 -0.005 -0.003 -0.006
(0.018) (0.018) (0.018) (0.036) (0.038) (0.036)
High 0.007 0.009 0.004 -0.091 -0.080 -0.089
(0.021) (0.022) (0.021) (0.048) (0.049) (0.048)
Retired 0.026 0.025 0.026 -0.012 -0.023 -0.013
(0.021) (0.021) (0.021) (0.038) (0.040) (0.038)
Married -0.037∗ -0.040∗ -0.038∗ 0.046 0.055 0.046
(0.016) (0.017) (0.016) (0.031) (0.032) (0.031)
Equiv. hh income (cube root) -0.001 -0.001 -0.001 -0.001 -0.001 -0.001
(0.001) (0.001) (0.001) (0.002) (0.002) (0.002)
Health access 0.020 0.021
(0.023) (0.033)
Supplementary insurance 0.019 -0.046
(0.021) (0.050)
Overestimating -0.147∗∗∗ -0.142∗∗∗ -0.149∗∗∗
(0.032) (0.033) (0.032)
Constant 1.306∗∗ 1.226∗∗ 1.324∗∗∗ 1.168 1.183 1.171
(0.398) (0.407) (0.398) (0.714) (0.753) (0.715)
Country dummies Yes Yes Yes Yes Yes Yes
N 33,984 32,023 33,921 5,840 5,417 5,812
AIC 192,107 180,867 191,768 37,858 35,136 37,681
BIC 192,317 181,084 191,987 38,025 35,308 37,855
Note: “Unimpaired” refers to the sample that is objectively unimpaired, i.e. able to stand up from the chair and “Impaired”
refers to the sample that is objectively impaired, i.e. unable to stand up from the chair. The dependent variable “doctor visits”
is based on the annual number of doctor visits, visits to emergency rooms and outpatient clinic visits at wave w + 1, i.e. Wave
6. All explanatory variables are taken from Wave 5. The estimated coefficients are based on a negative binomial regression
model with mean dispersion. Standard errors are clustered at the household level and presented in parentheses. * p<0.05, **
p<0.01, *** p<0.001
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Table A.9: Robustness analysis: Annual number of doctor visits at w + 1 by survey wave


















Chronic diseases 0.201∗∗∗ 0.176∗∗∗ 0.166∗∗∗ 0.143∗∗∗
(0.011) (0.006) (0.022) (0.010)
Activity limitations 0.114∗∗∗ 0.093∗∗∗ 0.045∗ 0.048∗∗∗
(0.021) (0.011) (0.019) (0.007)
Age -0.077∗ 0.004 0.011 0.028
(0.036) (0.012) (0.076) (0.021)
Age squared 0.001∗ 0.000 -0.000 -0.000
(0.000) (0.000) (0.001) (0.000)
Woman 0.050∗ 0.038∗∗ 0.173∗∗∗ -0.036
(0.023) (0.014) (0.052) (0.032)
Educ. group (ref.: low)
Medium -0.048 0.022 -0.014 -0.005
(0.029) (0.018) (0.067) (0.036)
High -0.032 0.007 -0.065 -0.091
(0.033) (0.021) (0.079) (0.048)
Retired 0.023 0.026 0.067 -0.012
(0.029) (0.021) (0.058) (0.038)
Married -0.012 -0.037∗ -0.103 0.046
(0.028) (0.016) (0.071) (0.031)
Equiv. hh income (cube root) -0.002 -0.001 -0.002 -0.001
(0.001) (0.001) (0.003) (0.002)
Constant 3.622∗∗ 1.306∗∗ 1.876 1.168
(1.118) (0.398) (2.440) (0.714)
Country dummies Yes Yes Yes Yes
N 12,083 33,984 1,961 5,840
AIC 68,559 192,107 12,603 37,858
BIC 68,736 192,317 12,737 38,025
Note: “Unimpaired” refers to the sample that is objectively unimpaired, i.e. able to stand up from the chair and “Impaired”
refers to the sample that is objectively impaired, i.e. unable to stand up from the chair. The dependent variable “doctor visits”
is based on the annual number of doctor visits, visits to emergency rooms and outpatient clinic visits at wave w + 1, i.e. Wave
4 or Wave 6. All explanatory variables are taken from wave w, i.e. Wave 2 or Wave 5 respectively. The estimated coefficients
are based on a negative binomial regression model with mean dispersion. Standard errors are clustered at the household level
and presented in parentheses. * p<0.05, ** p<0.01, *** p<0.001
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